Lyophilization

ABSTRACT

Embodiments of methods, systems, and apparatuses for lyophilizing, storing, and transfusing materials are described. In embodiments, the materials may include whole blood or a component of whole blood such as plasma.

CROSS-REFERENCE TO RELATED PATENT APPLICATION(S)

This application claims priority to: U.S. Provisional Patent ApplicationNo. 62/009,629, filed Jun. 9, 2014, entitled LYOPHILIZATION; U.S.Provisional Patent Application No. 62/010,027, filed Jun. 10, 2014,entitled LYOPHILIZATION; and U.S. Provisional Patent Application No.62/142,146 filed Apr. 2, 2015, entitled CONTAINER FOR LYOPHILIZATION.All three of the above-identified provisional patent applications arehereby incorporated by reference in their entirety as if set forthherein in full.

BACKGROUND

Lyophilization is a process that is used to preserve materials andincrease their shelf life, including biological materials, food, andpharmaceuticals. Lyophilization occurs by first freezing material tosolidify it and then subjecting the material to a low pressureenvironment (below atmospheric pressure) to allow for sublimation of acomponent of the material. Typically the component is a liquid atstandard temperature and pressure, one example being water.

Depending on the type of material and volume being lyophilized, theprocess may take several days to complete. There is a need to improvethe efficiency and shorten the time to lyophilize material withoutaffecting the ability to later use the final lyophilized product.

Embodiments of the present invention have been made in light of theseand other considerations. However, the relatively specific problemsdiscussed above do not limit the applicability of the embodiments of thepresent invention.

SUMMARY

The summary is provided to introduce aspects of some embodiments of thepresent invention in a simplified form, and is not intended to identifykey or essential elements of the claimed invention, nor is it intendedto limit the scope of the claims.

Some embodiments relate to containers for lyophilizing, storing, andtransfusing a blood component. The containers may include, inembodiments, a first wall comprising a flexible polymeric material and asecond wall attached to the first wall to define an interior volume ofthe container. The second wall in embodiments is made from a gaspermeable material that allows gas to move from an interior of thecontainer to an exterior. In some embodiments, the containers mayinclude a second chamber (or portion), where the lyophilized material isstored after processing.

Other embodiments relate to methods of lyophilizing a multi-componentliquid. In embodiments, the methods may involve maintaining themulti-component liquid in a container and subjecting the multi-componentliquid to a first pressure, which may be below atmospheric pressure. Atleast one component of the multi-component liquid may then be evaporatedfor a predetermined time. After the evaporation step, themulti-component liquid may be frozen to form a solid. In someembodiments, the multi-component liquid may be subjected to shaping,e.g., pressing with a compressive force, during the freezing step. Thesolid may then be subjected to a second pressure that in embodiments islower than the first pressure. A portion of the solid may then besublimated. A component of the solid may then be desorbed from thesolid.

Yet other embodiments relate to a system for lyophilizing amulti-component liquid. Embodiments of the system may include a firstplate with a first surface and a second plate with a second surfaceopposed to the first surface. The second plate may include channels forcirculating a fluid. The system may also include a plate moving systemthat is operable to increase and decrease a space between the firstsurface and the second surface. In some embodiments, the first plate mayinclude a second layer that forms the first surface. The second layermay in some embodiments be an infrared radiator for adding energy tomaterials that are being lyophilized.

BRIEF DESCRIPTION OF THE DRAWINGS

Non-limiting and non-exhaustive embodiments are described with referenceto the following figures.

FIG. 1 illustrates a first embodiment of an apparatus for lyophilizingmaterials.

FIG. 2 illustrates a second embodiment of an apparatus for lyophilizingmaterials.

FIG. 3 illustrates an embodiment of a shelf system.

FIG. 4 illustrates the shelf system of FIG. 3 with the plates havingbeen moved as compared to FIG. 3.

FIG. 5 illustrates a second embodiment of a shelf system.

FIG. 6 illustrates the shelf system of FIG. 5 with the plates havingbeen moved as compared to FIG. 5.

FIG. 7 illustrates an embodiment of a mechanism for moving two plates ofa shelf system that may be part of the systems shown in FIGS. 3-6.

FIGS. 8A and 8B illustrate first embodiments of a structure of twoplates that may be used as part of a shelf system.

FIG. 9 illustrates a second embodiment of a structure of two plates thatmay be used as part of a shelf system.

FIG. 10 illustrates a third embodiment of a structure of two plates thatmay be used as part of a shelf system.

FIG. 11 illustrates containers that may be used to store material forlyophilization.

FIG. 12 illustrates an exploded view of a container similar to thecontainers of FIG. 11.

FIG. 13 illustrates a cross sectional view of the container of FIG. 12maintaining a fluid.

FIG. 14 illustrates a cross sectional view of a three walled containeraccording to an embodiment.

FIG. 15 illustrates a cross sectional view of a three walled containeraccording to a second embodiment.

FIG. 16 illustrates a container that may be used to store material forlyophilization and after lyophilization according to embodiments.

FIGS. 17A-17C illustrate cross sections of the container illustrated inFIG. 16.

FIGS. 18A and 18B illustrate a container that may be used to storematerial for lyophilization and after lyophilization according to otherembodiments.

FIGS. 19A-19C illustrate a container that may be used to store materialfor lyophilization and after lyophilization according to otherembodiments.

FIGS. 20A-20C illustrate a container that may be used to store materialfor lyophilization and after lyophilization according to yet otherembodiments.

FIG. 21 illustrates an embodiment of a system for pooling and fillingcontainers with a biological fluid for later lyophilizing.

FIG. 22 illustrates an embodiment of a system for pooling a biologicalfluid, reducing a volume of the biological fluid, and filling containerswith the biological fluid for later lyophilizing.

FIG. 23 illustrates an embodiment of a system for pooling a biologicalfluid, pathogen reducing the fluid, and filling containers with thebiological fluid for later lyophilizing.

FIG. 24 illustrates an embodiment of a system for pooling a biologicalfluid, reducing a volume of the biological fluid, pathogen reducing thereduced volume of fluid, and filling containers with the biologicalfluid for later lyophilizing.

FIG. 25 depicts a bag containing fluid for treatment, and a shaker tablefor agitating the fluid while exposing the fluid to photoradiation froma light source in accordance with embodiments.

FIG. 26 illustrates an apparatus for reducing or inactivating pathogensand microorganisms in accordance with embodiments.

FIG. 27 illustrates a process for lyophilizing, storing, reconstituting,storing, and transfusing a blood component according to an embodiment.

FIG. 28 illustrates a flow chart of a process of lyophilizing materialaccording to an embodiment.

FIG. 29 illustrates a flow chart of a process for pathogen reducing andlyophilizing material according to an embodiment.

FIG. 30 illustrates an embodiment of system for lyophilizing materialusing IR radiation.

FIG. 31 illustrates another embodiment of system for lyophilizingmaterial using IR radiation.

FIG. 32 illustrates a flow chart of a process of lyophilizing materialusing IR radiation according to an embodiment.

FIG. 33 illustrates an embodiment of a computer system that may be usedto implement embodiments.

DETAILED DESCRIPTION

The principles of the present invention may be further understood byreference to the following detailed description and the embodimentsdepicted in the accompanying drawings. It should be understood thatalthough specific features are shown and described below with respect todetailed embodiments, the present invention is not limited to theembodiments described below.

Reference will now be made in detail to the embodiments illustrated inthe accompanying drawings and described below. Wherever possible, thesame reference numbers are used in the drawings and the description torefer to the same or like parts.

FIG. 1 illustrates a first embodiment of an apparatus 100 forlyophilizing materials (e.g., in the form of liquids, solids, orcombinations thereof) according to embodiments. As shown in FIG. 1,apparatus 100 includes a chamber 104, a housing 108, a shelf system 112,and an interface 116. Housing 108 houses, among other components, avacuum system for creating a low pressure (e.g., below atmosphericpressure) environment in chamber 104, a temperature control system forcontrolling the temperature of the shelf system 112, and a controlsystem, which may include a computer system (with one or moreprocessors) for controlling various functions of the apparatus 100. Userinterface 116 can be used by an operator to input data, parameters, andother information to control the functions of apparatus 100. In oneembodiment, user interface 116 may allow an operator to create and runcustom processes for lyophilizing material, including multi-stepprogrammable cycles.

In embodiments, material to be lyophilized is placed on the shelf system112 in chamber 104. The vacuum system may then bring the environment inchamber 104 to a first pressure, which may be a pressure belowatmospheric pressure. In some embodiments, the first pressure may beselected based on evaporation, while in a liquid state, of a componentin the material to be lyophilized. After the chamber 104 has reached thefirst pressure, at least a portion of the first component may beevaporated from the material. Evaporation may be performed for a firstperiod of time, or until a predetermined amount of the first componenthas been evaporated away from the material.

After the portion of the first component has been evaporated, theremaining material may be cooled to freeze any remaining liquid into asolid. In embodiments, the evaporation described above may be part ofthe freezing step. As can be appreciated, in some embodiments, theevaporation may cool off the remaining material to such an extent thatliquid freezes into a solid. In other embodiments, the freezing mayinvolve cooling using other mechanisms in addition to, or in lieu of,evaporation.

The vacuum system may bring the environment in chamber 104 to a secondpressure, which in embodiments may be lower than the first pressure.Under the second pressure, a second portion of the first component maybe sublimated from the material. In some embodiments, the sublimationmay also include sublimating other components of the material.

In some embodiments, after sublimation, the material may be maintainedat the second pressure for an additional period of time to desorb one ormore components from the material. The component that is desorbed may bepreviously absorbed or adsorped by the material.

As described in greater detail below, in embodiments, the shelf system112 may include features that transfer/add energy to, or remove energyfrom, the material being lyophilized. The addition or removal of energymay be used in one or more of the steps described above. For example,the shelf system 112 may be used to add energy to the material to effectthe evaporation of the component from the material. The shelf system 112may also be used to remove energy of the system to cool the material andfreeze any liquid in the material into a solid. The shelf system 112 mayalso be used, in embodiments, to add energy to the material during thesublimation step.

FIG. 2 illustrates a second embodiment of an apparatus 200 forlyophilizing materials according to embodiments. Apparatus 200 hassimilar features as apparatus 100 including a chamber 204 that is housedwithin housing 208. Apparatus 200 also includes a shelf system 212 and auser interface 216. Apparatus 200 may, in embodiments, provide similarfunctionality and operate similarly as apparatus 100. It is noted thatapparatus 100 and apparatus 200 are shown and described merely toillustrate that embodiments may be implemented in any lyophilizationapparatus or system and are not limited to any particular design orarrangement of system components.

Below various structures may be described as being part of embodimentsof a lyophilization apparatus or system, e.g., apparatus 100 orapparatus 200. However, the present invention is not limited thereto.Various steps of a lyophilization process may be performed by differentstructures, apparatuses, or systems. As one non-limiting example, theevaporation step, the freezing step, and the sublimation step (describedabove) may, in some embodiments, be performed by three separateapparatuses each performing a single step. In other embodiments, one ormore apparatuses may have various functionalities allowing more than onestep of a lyophilization process to be performed in one apparatus.

As one example, an evaporation step may be performed in an apparatusthat also performs a freezing step. As described below with respect toFIG. 29, evaporation may cool material during a freezing step. After theevaporation and freezing, the material may be transferred to anapparatus that sublimates a component of the material.

In some embodiments, an apparatus may be used to evaporate a liquidcomponent from a material in a first apparatus. The material may then betransferred to a second apparatus where the material is frozen. Afterfreezing, the material may be returned to the first apparatus forlyophilization.

In other embodiments, an evaporation step may not be performed as partof a process. Material may be frozen in one apparatus and then thematerial may be transferred to a second apparatus for sublimation. Asthe embodiments described above illustrate, the present invention is notlimited to performing a process on any one apparatus but may involvesteps performed on multiple apparatuses.

FIG. 3 illustrates an embodiment of a shelf system 300 that may be usedin a lyophilization process/apparatus for example apparatus 100 orapparatus 200 described above. Shelf system 300 includes plates 304 thatmake up shelves 320 and provide a surface for placing material to belyophilized. Depending on the type of material to be lyophilized, thematerial may be maintained within a container such as a tray, bag, orbottle and the container placed on the plates 304. FIG. 3 illustratescontainers on the plates 304. The containers store material to belyophilized. Shelf system 300 also includes an end plate 308, which inembodiments may be stationary as described in greater detail below.

Additionally, shelf system 300 also includes a movement control system312 that may be used in embodiments to change the distance betweenplates 304. As described in detail below, the distance between plates304 can be changed so that materials to be lyophilized may be shaped bybeing pressed, during a freezing step of a lyophilization process. Themovement control system 312 may be designed, in embodiments, to moveplates 304 toward, and away from, each other.

FIG. 4 illustrates shelf system 300 with plates 304 moved, e.g., in afully collapsed position, to compress material during a lyophilizationprocess, and in particular during a freezing step of a lyophilizationprocess. As shown in FIG. 4, end plate 308 remains in the same positionas is shown in FIG. 3, however each of plates 304 have moved up, withthe first plate (right below end plate 308) having moved the leastamount and the seventh plate (furthest away from end plate 308) havingmoved the most amount. In the collapsed position shown in FIG. 4,pressure is applied to each of the containers on the plates 304 to pressthe containers and the material. In other words, a compressive force isapplied to the container and material within the container. As describedin greater detail below, it is believed that the application ofpressure, e.g., pressing a container, may provide some benefit to theprocess of lyophilization and is used in some embodiments.

As may be appreciated, the movement control system 312 may include anumber of different components that are used to move plates 304. Forexample, movement control system 312 may include, in embodiments,computer system(s), such as controllers, that include processor(s),memory, input devices, output devices, communication devices, or anycombination thereof. Movement control system 312 may also include othersubsystems such as hydraulic, pneumatic, or mechanical systems that mayinclude one or more motors, actuators, pumps, compressors, cylinders,pistons, tubing, valves, bladders, sensors, regulators, or anycombination thereof.

System 300 also includes a thermal fluid system 316. The thermal fluidsystem 316 circulates a thermal fluid through at least a portion ofshelves 320 to control the temperature of at least some of the plates304 and consequently material that is position on the plates 304 forlyophilization. Thermal fluid system 316 may be used in removing oradding energy to plates 304 of shelves 320, during various steps of alyophilization process.

FIG. 5 illustrates another embodiment of a shelf system 500 that may beused in a lyophilization process/apparatus for example apparatus 100 orapparatus 200 described above. Shelf system 500 includes shelves 520,which provide a surface for placing material to be lyophilized. Thematerial may be maintained within a container such as a tray, bag, orbottle and the container placed on first plates 504 of shelves 520.Shelf system 500 also includes second plates 508 that are also part ofshelves 520 and that are opposed to, and positioned above at least oneof first plates 504. Additionally, shelf system 500 also includes amovement control system 512 that may be used in embodiments to changethe distance between first plates 504 and second plates 508 of shelves520. As described in greater detail below, the distance between firstplates 504 and second plates 508 can be changed to apply some pressureto materials that are being lyophilized. The movement control system 512may be designed, in embodiments, to move first plates 504 toward, andaway from, stationary second plates 508, while in other embodimentssecond plates 508 may be moved toward, and away from, stationary firstplates 504. In yet other embodiments, the movement control system 512may be designed to move both first plates 504 and second plates 508toward and away from each other.

Movement control system 512 may include any appropriate system(s) formoving plates 504 and/or 508 of shelves 520, and may, in embodiments,have similar components as movement control system 312 (FIG. 3),including computer system(s), such as controllers, that includeprocessor(s), memory, input devices, output devices, communicationdevices or any combination thereof. System 512 may also include othersubsystems such as hydraulic, pneumatic, or mechanical systems that mayinclude one or more motors, actuators, pumps, compressors, cylinders,pistons, tubing, valves, bladders, sensors, regulators, or anycombination thereof.

FIG. 6 illustrates shelf system 500 from FIG. 5, with the plates 504 and508, of shelves 520, moved to press material during a lyophilizationprocess, and in particular during a freezing step of a lyophilizationprocess. As shown in FIG. 6, second plates 508 have been moved downtoward first plates 504. In the position shown in FIG. 6, pressure isapplied to each of the containers on the first plates 504 by applyingsome pressure with the second plates 508. The application of somepressure, and/or generally shaping the material during freezing, isbelieved to improve the efficiency in the process of lyophilization andis used in some embodiments.

System 500 also includes a thermal fluid system 516, which may besimilar to thermal fluid system 316. The thermal fluid system 516circulates a thermal fluid within at least some portion of shelves 520to control the temperature of at least some of the plates 504, 508 andconsequently material that is on the plates 504, 508 for lyophilization.Thermal fluid system 516 may be used to remove or add energy to shelves520, during various steps of a lyophilization process as described ingreater detail below.

The description of the shelf systems 300 and 500 above are provided forpurposes of illustrating some features of embodiments of the presentinvention. It is noted that embodiments of the present invention mayinclude additional features that are not described above but are stillwithin the scope of the present invention. For example, the number ofplates in the system may vary. In some embodiments, the plates forholding material to be lyophilized (e.g., 304, 504) may be more than two(2), more than three (3), more than four (4), more than 5, or more than(6). In other embodiments, the plates for holding material to belyophilized (e.g., 304, 504) may be less than twelve (12), less than(11), less than ten (10), less than nine (9), or less than (8). In oneembodiment, there are seven (7) plates for holding material to belyophilized (e.g., 304, 504).

In other embodiments, the plates for holding material to be lyophilized(e.g., 304, 504) may have other features. For example, the plates mayhave a raised lip around the perimeter to ensure that any leakages aremaintained on the plate and can be easily cleaned up. Also, the platesmay be connected to the movement control systems (312, 512) and/orthermal fluid systems (316, 516) using any appropriate connectionsincluding connectors, tubing, fittings, pipes, adapters etc. In oneembodiment, the plates are connected so that they may be easilydisconnected (e.g., using quick disconnect valve fittings) from themovement control systems (312, 512) and/or thermal fluid systems (316,516) to allow them to be easily cleaned.

FIG. 7 illustrates an embodiment of a system 700 that includes twoplates and a mechanism for moving plates that may be part of the shelfsystems 300 or 500 shown in FIGS. 3-6. First plate 704 is positionedabove a second plate 708 such that surface 712 of first plate 704 isopposed to surface 716 of second plate 708. As shown in FIG. 7, a space720 is defined between the two surfaces 712 and 716 where material isplaced to be lyophilized. As illustrated by arrow 724, the space 720 maybe increased or decreased by movement of one or more of plates 704 and708. The space 720 may be decreased so that in embodiments the materialto be lyophilized may be pressed during one or more steps of thelyophilization process. The space 720 may be increased to relieve thepressure, or when positioning material to be lyophilized onto plate 708.

It is noted that any mechanism for moving one or more of plates 704 and708 may be used with embodiments. FIG. 7 illustrates one example of amechanism for moving the plates 704 and/or 708 to increase or decreasethe size of space 720. In the embodiment shown in FIG. 7, supportmembers 728 are designed to be attached to both plates 704 and 708, aswell as allow movement of plates 704 and 708 toward and away from eachother.

Support members 728 may include an outer support 732 and an innersupport 736. For example, outer support 732 may be a hollow tube withthe inner support 736 being a shaft positioned inside the hollow tube.In some embodiments, one of plates 704 or 708 may be attached to theouter support 732 and the other may be attached to the inner support736. The plates 704, 708 may be attached to the support member(s) 728 byany suitable mechanism one non-limiting example includes the use ofL-bracket(s) such as L-bracket 740. Also, in some embodiments, fastenerssuch as screws, nuts, bolts, washers, or any combination thereof, may beused to attach plates 704 and 708 to portions of support members 728.

In the embodiment shown in FIG. 7, outer support 732 includes an opening744 to allow L-bracket 740 to attach to inner support 736 and stillallow the L-bracket 740 to move vertically. The movement of L-bracket740, which is attached to one of plates 704 or 708, increases ordecreases space 720.

In embodiments, at least portions of support members 728 are connectedto a movement control system such as movement control system 312 (FIGS.3 and 4) or movement control system 512 (FIGS. 5 and 6). As noted above,the movement control system may be used to control the distance of space720, and may increase space 720 during loading and some lyophilizationsteps, and decrease space 720 during some lyophilization steps to pressthe material being lyophilized.

It is noted that the support members 728 and bracket 740 are merely oneexample of a mechanism for moving plates 704 and 708. In otherembodiments, different components may be used as part of differentmechanisms for moving plates 704 and 708; non-limiting examples includebrackets, rails, fasteners, bearings, bushings, shafts, tubes, plates,welds, or any combination thereof.

Plates 704 and 708 in FIG. 7 are illustrated as merely one embodiment ofa plate structure that may be part of a shelf system such as the shelfsystems 300 or 500 shown in FIGS. 3-6. Other embodiments may utilizedifferent structures or designs. As noted above, other embodiments mayhave different mechanisms for changing the distance of space 720 betweenplates 704 and 708. Other shelf systems may also include more than thetwo support members 728 shown in FIG. 7, such as four or more supportmembers located near the four corners of plates 704 and 708. This ismerely another example, and other embodiments are included within thescope of the present invention.

FIGS. 8A and 8B illustrates a first embodiment of a two plate structure800 that may be used as part of a shelf system, such as system 300illustrated in FIGS. 3 and 4. The structure 800 includes a first plate804 and a second plate 808. First plate 804 includes a surface 812 thatis opposed to a surface 816 of plate 808. The two opposed surfaces 812and 816 define a space 820 between them.

Each of plates 804 and 808 in embodiments has similar structures. Plate804 has a first layer 828, which in embodiments may be made from athermally conductive material. The first layer 828 includes channels 824that provide a flow path for a thermal fluid. The thermal fluid may beused in embodiments to control the temperature of the first layer 828 byheating or cooling the first layer 828.

The plate 804 may also include an interface 832 between the first layer828 and a second layer 836. In embodiments, interface 832 may includethermal insulating material that allows the temperature of first layer828 to be different than the temperature of second layer 836. In otherembodiments, interface 832 may alternatively, or in addition, haveproperties that help adhere second layer 836 to first layer 828.

In one embodiment, second layer 836 comprises an IR radiating material,which in embodiments may be a ceramic material, metallic material,intermetallic material, and/or a composite material. In particularembodiments, the material may be an infrared (IR) radiator that radiatesIR energy. In these particular embodiments, the second layer 836 mayinclude embedded elements for heating layer 836 to facilitate IRradiation from surface 812. For example, the second layer 836 mayinclude, electrodes, heating element(s), sensor(s) (e.g.,thermocouple(s)), and/or combinations thereof. As discussed in greaterdetail below, the IR energy radiated by second layer 836 from surface812 may be used in performing some steps of a lyophilization process. Asis shown in the embodiment of FIGS. 8A and 8B, plate 808 has a similarstructure as plate 804 with similar first layer 848, second layer 856,interface 852, and channels 844 for circulating thermal fluid.

In embodiments, plate structure 800 may be used in shelf system 300(FIGS. 3 and 4) as part of a lyophilization apparatus that also includesother components such as a vacuum system for creating a low pressureenvironment around at least the shelves of shelf system 300. In theseembodiments, plates 804 and 808 may comprise part of shelves 320 and beconnected to shelf movement system 312, as well as thermal fluid system316.

In operation, shelf system 300 (with plate structure 800) may bepositioned within a vacuum chamber (e.g., 104 or 204) that is used tocreate a low pressure (below atmospheric pressure) environment around atleast the shelves 320 (e.g., plates 804 and 808) of system 300. Shelfmovement system 312 may then increase space 820 to allow container 840(containing material 860, which in embodiments may be a liquid such as abiological liquid) to be positioned onto surface 816 of plate 808.System 312 may then move one or more plates 804 and/or 808 to decreasespace 820 and slightly press on container 840 (as shown in FIG. 8). Inembodiments, thermal fluid system 316 may then circulate a thermal fluidthrough channels 844 of plate 808 to cool first layer 848 of plate 808,and consequently the material 860 within container 840.

Without being bound by theory, it is believed that pressing the materialto be lyophilized, e.g., material 860 in container 840, during afreezing step, may shape the material to create a more uniformcross-section of material 860. Accordingly, it is believed that the moreuniform cross-section will increase the efficiency of removing acomponent, e.g., in embodiments ice, from the material 860 during asubsequent sublimation step. In other words, reducing variations inthickness may allow sublimation to occur at a uniform rate as thesublimation interface advances through the material 860.

After material 860 has been frozen, the environment around shelves 320may be brought to a low pressure to promote sublimation of at least onecomponent of the material 860. Shelf movement system 312 may thenincrease space 820 in preparation for the sublimation step. In addition,the thermal fluid may be circulated through channels 844 to add thermalenergy to material 860 in container 840 (through first layer 848, whichwould be made from a thermally conductive material) to promotesublimation of a component in material 860.

As noted above, in some embodiments, second layer 836 may comprises anIR radiator. In these embodiments, the IR radiator may be activated todirect IR energy to material 860 in container 840. The IR energy mayprovide additional energy for sublimating a component from material 860.In these embodiments, the sublimation step may be completed more quicklyby the addition of both thermal energy (from thermal fluid circulatingin channels 844) as well as IR energy (from IR radiator in second layer836 of plate 804).

In some embodiments, after sublimation, the material 860 may bemaintained at the low pressure with the continued addition of energy(thermal and/or IR). In some embodiments this is done to remove thesame, or some additional component, that is chemically combined withother compound(s) in the material 860. As one example, water ofhydration may be removed during this step.

Once the component has been removed from material 860 by sublimation,the environment around shelves 320 may be brought to atmosphericpressure and the material 860 (and container 840) may then be removedfrom plate 808 for storage or additional processing.

As may be appreciated, structure 800 also allows a plate (e.g., plate804 or 808) to be used to process material positioned both below andabove the plate. For example, as described above, second layer 836 mayinclude an IR radiator to add energy to material located beneath it.However, first layer 828 may be used to cool the material positionedabove the first layer 828 and freeze any liquid in the material into asolid, as well as add thermal energy to the material (e.g., bycirculating thermal fluid in channels 824). Similarly, second layer 856of plate 808 may be used as an IR radiator for material positioned belowsecond layer 856, while as noted above first layer 848 may be used tocool the material 860 and freeze any liquid in the material and addthermal energy during the sublimation step.

FIG. 8B illustrates another embodiment of plate structure 800. In thisembodiment, plate 808 has features that are shaped to hold a containerand/or material for lyophilization. As shown in FIG. 8B, plate 808includes a lip 864 that in embodiments corresponds to at least a portionof the shape of the container 840. Lip 864 may be used in embodiments todefine a location where a container 840 may be placed on plate 808.Also, in some embodiments when plate 804 is used to press container 840.Lip 864 may be used to ensure that container 840 does not move whenbeing pressed by plate 804 and may also be used as a form, during afreezing step, for the material being lyophilized.

In some embodiments, lip 864 may surround only a portion of a container.For example, the lip may be on two sides of the container, on threesides of the container, or be discontinuous around some portion of thecontainer but not others.

The description above regarding use of plate structure 800 in shelfsystem 300 is provided merely for illustrative purposes. Alyophilization process that utilizes plate structure 800 and shelfsystem 300 may include additional steps not described above. Thedescription above is not intended to be complete and is provided merelyto illustrate some features of plate structure 800.

FIG. 9 illustrates a second embodiment of a two plate structure 900 thatmay be used as part of a shelf system, such as part of shelves 320 insystem 300 (FIGS. 3 and 4). Structure 900 has some similar features tostructure 800 described above. Structure 900 may include a first plate904 and a second plate 908. First plate 904 includes a surface 912 thatis opposed to a surface 916 of plate 908. The two opposed surfaces 912and 916 define a space 920 between them.

As is illustrated in FIG. 9, surface 916 includes some features, e.g.,ridges 960. The features are provided to create a surface that has animproved heat and/or mass transfer surface area. In embodiments, thismay be accomplished by imparting a macro texture. For example, ridges960 and 964 may impart a texture to a surface on a material during afreezing step of a lyophilization process. Without being bound bytheory, it is believed that the improved heat and/or mass transfersurface area on the material may promote sublimation (of a component ofthe material being lyophilized) during a sublimation step. Although,surface 912 is shown with ridges 964 and surface 916 is shown withridges 960, it is noted that surfaces 912 and 916 may include othertypes of textures that may provide improved surface area for heat andmass transfer. As one non-limiting example, surface 916 may have somepattern (random or regular) of concave and/or convex half spheres of thesame or different sizes.

In one embodiment, the size, shape, or geometry of the features maydepend upon a number of considerations. For example, for features onsurface 916, the features may depend upon factors that affect thetransfer of thermal energy to the material being lyophilized, forexample the stiffness of the container in which the material to belyophilized is stored. The stiffness of the container may affect thecontact between the material to be lyophilized and the surface 916,which may affect the thermal energy transfer.

Each of plates 904 and 908 in embodiments has similar structures whichmay be different in other embodiments. Plate 904 has a first layer 928,which in embodiments may be made from a thermally conductive material.The first layer 928 includes channels 924 that provide a flow path for athermal fluid. The thermal fluid may be used in embodiments to controlthe temperature of the first layer 928 by heating or cooling the firstlayer 928.

Plate 904 may also include an interface 932 between the first layer 928and a second layer 936. In embodiments, interface 932 may includethermal insulating material that allows the temperature of first layer928 to be different than the temperature of second layer 936. In otherembodiments, interface 932 may alternatively, or in addition, haveproperties that help adhere second layer 936 to first layer 928.

In one embodiment, second layer 936 comprises an IR radiating material.In particular embodiments, the IR radiating material may be an infrared(IR) radiator that radiates IR energy. In these particular embodiments,the second layer 936 will include embedded electrodes for heating layer936 and a surface 912 for radiating IR energy. The IR energy may be usedin performing some steps of a lyophilization process. As is shown in theembodiment of FIG. 9, plate 908 has a similar structure as plate 904with similar first layer 948, second layer 956, interface 952, andchannels 944 for circulating thermal fluid.

FIG. 10 illustrates a third embodiment of a two plate structure 1000that may be used as part of a shelf system, such as shelves 520, ofsystem 500 illustrated in FIGS. 5 and 6. Structure 1000 may include afirst plate 1004 and a second plate 1008. First plate 1004 includes asurface 1012 that is opposed to a surface 1016 of plate 1008. The twoopposed surfaces 1012 and 1016 define a space 1020 between them wherematerial to be lyophilized may be positioned.

Plates 1004 and 1008 in embodiments have a different structure. Plate1004 has a first layer 1028, which in embodiments may be made from athermally conductive material. The first layer 1028 includes channels1024 for circulating a thermal fluid. Plate 1004 may also include aninterface 1032 between the first layer 1028 and a second layer 1036. Inembodiments, interface 1032 may include thermal insulating material thatallows the temperature of first layer 1028 to be different than thetemperature of second layer 1036. In other embodiments, interface 1032may alternatively, or in addition, have properties that help adheresecond layer 1036 to first layer 1028.

In one embodiment, second layer 1036 comprises an IR radiating material.In particular embodiments, the IR radiating material may be an infrared(IR) radiator that radiates IR energy. In these particular embodiments,the second layer 1036 will include embedded elements for generating andradiating IR energy. For example, the second layer 1036 may include,electrodes, heating element(s), sensor(s) (e.g., thermocouple(s)),and/or combinations thereof. The IR energy radiated by second layer 1036may be used in performing some steps of a lyophilization process.

As is shown in the embodiment of FIG. 10, plate 1008 may include a layer1040. In embodiments, the layer 1040 may be made from a thermallyconductive material. The layer 1040 may include channels 1044 thatprovide a flow path for circulating a thermal fluid. The thermal fluidmay be used in embodiments to control the temperature of the layer 1040by heating or cooling the first layer 1040 and any material positionedon surface 1016, which may be undergoing lyophilization.

In embodiments, plate structure 1000 may be used in shelf system 500(FIGS. 5 and 6) as part of a lyophilization apparatus that also includesother components such as a vacuum system for creating a low pressure(below atmospheric pressure) environment around the shelf system 500. Inthese embodiments, plates 1004 and 1008 may be part of shelves 520 andbe connected to shelf movement system 512 as well as thermal fluidsystem 516.

In operation, shelf system 500 with plate structure 1000 (as part ofshelves 520) may operate similar to shelf system 300 with platestructure 800 as described above. The plate structure 1000 as part ofshelves 520 may be positioned within a vacuum chamber that is used tocreate a low pressure, e.g., less than atmospheric pressure, environmentaround at least the shelves 520 of system 500. Shelf movement system 512may then be operated to increase space 1020 to allow a container(containing material, e.g., a biological liquid, to be lyophilized) tobe positioned onto surface 1016 of plate 1008. System 512 may then moveone or more plates 1004 and/or 1008 to decrease space 1020 and press thecontainer with material to create a layer of material of substantiallyuniform thickness. In embodiments, thermal fluid system 516 may thencirculate a thermal fluid through channels 1044 of plate 1008 to coollayer 1044 of plate 1008, and consequently the material to belyophilized.

As noted above, (without being bound by theory) it is believed thatpressing the material to be lyophilized, during a freezing step, maycreate a more uniform cross-section of material. Accordingly, it isbelieved that the more uniform cross-section will increase theefficiency of removing a component, such as ice, from the materialduring a subsequent sublimation step. In other words, reducingvariations in thickness may allow sublimation to occur at a uniform rateas the sublimation advances through the material making the sublimationstep more efficient and possibly shorter.

In other embodiments, during a freezing step, the material to belyophilized may be shaped or formed, e.g., on a surface. For example, asnoted above, a texture may be imprinted on the material to increasesurface area, see e.g., FIG. 9. In other embodiment, the material may beshaped based on the shape of a shelf or the container storing thematerial.

After the material on surface 1016 has been frozen, the environmentaround shelves 520 (with plate structure 1000) may be brought to a lowpressure to promote sublimation of at least one component of thematerial. Shelf movement system 512 may then increase space 1020 inpreparation for the sublimation step. In addition, the thermal fluid maybe circulated through channels 1044 to add some thermal energy to thematerial to promote sublimation of a component in the material.

As noted above, in some embodiments, second layer 1036 is a layer thatcomprises an IR radiator. In these embodiments, the IR radiator may beactivated to direct IR energy to the material on surface 1016. The IRenergy may provide additional energy for sublimating a component fromthe material. In these embodiments, the sublimation step may becompleted more quickly by the addition of both thermal energy (fromthermal fluid circulating in channels 1044) as well as IR energy (fromIR radiator in second layer 1036 of plate 1004).

In some embodiments, only IR energy may be used to perform thesublimation step. As noted above, the IR radiator in second layer 1036may add energy to the frozen material. In some of these embodiments,thermal fluid circulating in channels 1044 may be used to cool thematerial being lyophilized. Without being bound by theory, it isbelieved that during a lyophilization process, sublimation of materialtakes place at a surface of the material. When thermal energy is appliedto a bottom surface of the material (e.g., when using a plate structureshown in FIG. 10) to be lyophilized, the energy must be conducted to thetop surface where the sublimation is taking place. While the heattravels through the material, it may raise the temperature of thematerial to a point where a component, e.g., ice, melts, making it evenmore difficult to transfer thermal energy to the surface of thematerial.

As a result, in some embodiments, only IR energy is used to sublimatethe material. In addition, to avoid any melting, thermal energy may beremoved from a bottom surface of the material to cool the material andavoid any melting. For example, referring to FIG. 10, material may bepositioned in space 1020 for sublimation. An IR radiator in second layer1036 may be used to provide IR energy to the material to sublimate acomponent of the material from a top surface of the material opposed tosecond layer 1036. To avoid any melting that may take place, thermalfluid in channels 1044 may be circulated at a temperature that removesenergy, e.g., acts as a heat sink, to keep the material cool andavoiding any melting. These are merely some examples of processes thatmay be performed using the plate structure shown in FIG. 10. Otherembodiments may utilize the plate structure in FIG. 10 in performingprocesses that include different steps.

In some embodiments, after sublimation, the material may be maintainedat the low pressure (e.g., less than atmospheric pressure) with thecontinued addition of energy (thermal and/or IR). In some embodimentsthis is done to remove the same, or some additional component that ischemically combined with other compound(s) in the material. As oneexample, water of hydration may be removed during this step.

Once the component (e.g., sorbed component) has been removed from thematerial by sublimation, the environment around shelves 520 may bebrought to atmospheric pressure and the material may then be removedfrom plate 1008 for storage or subsequent processing.

It is noted that although the description above of plate structures 800,900, and 1000 has been made with respect to embodiments that incorporatethe plate structures in a lyophilization apparatus or system, e.g.,apparatus 100 or apparatus 200, the present invention is not limitedthereto. In other embodiments, plate structures 800, 900, and 1000 maybe part of different apparatuses that are used as part of alyophilization process that is not performed in a single apparatus. Asone non-limiting example, the evaporation step and the freezing stepdescribed above may be performed in an apparatus that includes one ormore features of plate structures 800, 900, or 1000. The sublimationstep may then be performed in another machine that may incorporate thesame, different, or none of the features of plate structures 800, 900,or 1000.

As another example, a process may involve only a freezing and asublimation step. The freezing step may be performed in an apparatusthat includes one or more features of plate structures 800, 900, or1000, or other features that may for example shape the material duringfreezing. The sublimation step may then be performed in another machinethat may incorporate the same, different, or none of the features ofplate structures 800, 900, or 1000.

As one additional example, the freezing step that may include creating asurface on material that has improved heat and mass transfer surfacearea may be performed in a separate apparatus. In these embodiments,features of plate structure 900 may be used in the apparatus. Priorstep, and subsequent steps, may be performed by one or more differentapparatuses.

Furthermore, although specific features have been described above, it isnoted that other embodiments may include additional structures,processes, or steps and still be within the scope of the presentinvention. As one non-limiting example, a lyophilization process mayinvolve sterile material that must remain sterile. In these embodiments,the apparatuses may include features that for example maintain sterilityof shelf systems, plates, or other structures used in the lyophilizationprocess. The sterility may be maintained using a variety of systems somenon-limiting examples including a UV (ultraviolet) radiation system,microwave systems, washing systems, steam systems, pressure systems,additional vacuum systems, filter systems, and/or combinations thereof.As one example, a UV radiation system with UV lamps or UV LED's may beutilized to sterilize components of a lyophilization apparatus or systemto maintain a sterile environment for materials being lyophilized thatmust be maintained sterile.

FIG. 11 illustrates an embodiment of containers 1100A and 1100B that maybe used to store material for lyophilization. As shown in FIG. 11,containers 1100A and 1100B are positioned on plates 1104 and 1108 whichmay be part of a shelf system in a lyophilization apparatus such asapparatus 100 or apparatus 200.

FIG. 12 illustrates an exploded view of container 1200, which includessimilar features as containers 1100A and 1100B. Container 1200 includesa first wall 1204, a second wall 1208, and three port connectors 1212,1216, and 1220. As illustrated in FIG. 12, the three port connectors1212, 1216, and 1220 are positioned between first wall 1204 and secondwall 1208. The port connectors may be used to connect to othercontainers, in some embodiments, in order to fill container 1200 withmaterial for lyophilization, to add a liquid to container 1200 toreconstitute the lyophilized material, and/or to remove material fromcontainer 1200 (e.g., reconstituted lyophilized material). Inembodiments, port connectors 1212, 1216, and 1220 may not be positionedbetween the first wall 1204 and the second wall 1208. For example, inembodiments, one or more of port connectors 1212, 1216, or 1220 may beintegrated into one of walls 1204 or 1208.

First wall 1204 may in some embodiments be made from a material that ispermeable to at least some gasses. For example, 1204 may be made of amaterial that has a relatively high permeability to water vapor but lowpenetration of liquid water, i.e., is water resistant. Furthermore, inother embodiments, first wall 1204 is also made of a material that isbiocompatible. Non-limiting examples of possible materials for use infirst wall 1204 include materials made from flashspun high-densitypolyethylene (HDPE) and polytetrafluoroethylene (PTFE). In oneembodiment, first wall 1204 may include a non-woven textile thatincludes fibers made from flashspun HDPE. In other embodiments, thefirst wall 1204 may be made from copolymers such as polyethylenecopolymers, vinyl copolymers, acrylic copolymers, polypropylenecopolymers, or amide copolymers that may be cast on a substrate (e.g.,woven or nonwoven textile). In one specific embodiment, first wall 1204may be made of an acrylic copolymer cast on a nylon nonwoven textile.

In embodiments, wall 1204 may be made from materials that aremanufactured using particular processes. For example, as noted above,the materials may be manufactured using a spinning process including,without limitation, flashspun, spunbonded, dry-laid, wet-laid, meltblow, and spunlaced. These processes may produce nonwoven textiles, ormay be used to generate fibers that are further processed, e.g., bystretching, weaving, etc. As another example, the materials may includepolymers or copolymers that are cast on a substrate such as a woven ornonwoven textile. Any of these processes may be used in making thematerial of first wall 1204 to create the material with the desiredproperties, gas permeability, tensile strength, water resistance, etc.

In embodiments, first wall 1204 has a water vapor transmission ofgreater than about 15 metric perms (perms are metric perms unlessotherwise noted), greater than about 20 perms, greater than about 25perms, greater than 30 perms, greater than about 35 perms. In otherembodiments, the water vapor transmission of first wall 1204 may begreater than about 50 perms, greater than about 75 perms, or greaterthan 100 perms, greater than about 150 perms or even greater than about200 perms. In some embodiments, first layer 1204 has a water vaporpermeability of between about 10 perms to about 70 perms, such asbetween about 15 perms and about 65 perms, or between about 20 perms andabout 60 perms. In other embodiments, first layer 1204 may have a watervapor permeability of between about 50 perms to about 1000 perms, suchas between about 100 perms and about 750 perms, or between about 200perms and about 500 perms. Also, in some embodiments, the first layer1204 may have a water resistance (i.e. hydrostatic head) of greater thanabout 100 cm, greater than 150 cm, greater than about 200 cm, and evengreater than about 250 cm. In some embodiments, first layer 1204 has awater resistance value of between about 50 cm to about 400 cm, such asbetween about 100 cm and about 350 cm, or between about 150 cm and about300 cm. It is noted that in some embodiments, layer 1204 may have any ofthe above-mentioned water vapor transmission values in combination withany of the above-mentioned water resistance values. In some embodiments,wall 1204 may be made from material that includes a nonwoven textilemade from polymer fibers manufactured using a spinning process. In otherembodiments, wall 1204 may be made from material that includes acopolymer cast on a nonwoven textile. These materials may bemanufactured specifically to provide the water vapor transmission andwater resistance values described above.

In embodiments, wall 1208 may be made from any suitable materialincluding polymers. In some embodiments, wall 1208 is made from atransparent or translucent material, non-limiting examples includingpolycarbonate, acrylics, polystyrene, polysulfone, polyethylene,polyolefin, polypropylene, polyvinylchloride, or combinations thereof.The use of a transparent or translucent material may be useful inembodiments where the material within container 1200 may be subjected toa pathogen reduction process that involves the use of a photosensitizerand illumination. In these embodiments, container 1200 may be able to beused as an illumination container. In embodiments, wall 1208 is alsobiocompatible, including at temperatures and pressures typical of alyophilization process. In embodiments, wall 1208 includes a polyolefinmaterial.

Wall 1208 may in some embodiments be a single sheet of material, such aswhen container 1200 is a bag. In other embodiments, wall 1208 mayprovide some depth for material that is stored in container 1200. Inthese embodiments, wall 1208 may be in the form of a tray.

FIG. 13 illustrates a cross sectional view of container 1200 showingvolume 1240. As shown in FIG. 13, wall 1204 is attached to wall 1208 atone or more joints 1224. Therefore, in addition to the properties ofwalls 1204 and 1208 mentioned above, the walls are also in embodimentsmade of materials that are compatible with each other to allow them tobe attached together to form container 1200. Walls 1204 and 1208 may beattached together using one or more suitable techniques, somenon-limiting examples including heat sealing, ultrasonic welding, RFwelding, solvent welding, laser welding, adhesive bonding, and/orcombinations thereof.

In one embodiment, container 1200 is used to lyophilize a biologicalfluid such as plasma 1244 (e.g., human plasma) shown in FIG. 13maintained within volume 1240. In this embodiment, wall 1204 may be madeof a material with a water vapor transmission of greater than about 35perms and a water resistance of greater than about 100 cm so that duringsublimation of ice, water vapor may escape through layer 1204 easily,but the liquid plasma will not leak out of volume 1240. Also, the waterresistance is useful when the plasma is reconstituted using a waterbased solution.

In addition to the other features of container 1200, it may also, inembodiments, be capable of maintaining the material to be lyophilizedsterile. That is, both walls 1204 and 1208 provide barriers topathogens, bacteria, or other microorganisms to prevent contamination ofthe material within container 1200. This feature may be particularlyuseful in situations where the material to be lyophilized is abiological fluid that may be later infused into a patient. The abilityto maintain a closed sterile environment within container 1200 avoidsthe need to ensure sterility of the environment during lyophilization.In other words, the lyophilization process may not require sterilizationof the apparatus(es) used in the process before performing the varioussteps of the lyophilization process. This may eliminate the need forexpensive vacuum systems, filter systems, or other systems used in aclean room environment. In these embodiments, the container 1200maintains a closed system during lyophilization and additional handlingof container 1200 (e.g., storing, rehydrating the lyophilized material,and utilizing the rehydrated material).

FIG. 14 illustrates a cross sectional view of an embodiment of a threewalled container 1400 with a volume 1440 storing a biological fluid(e.g., human plasma), for example, plasma 1444. As shown in FIG. 14,container 1400 includes a third wall 1404, a first wall 1408, and asecond wall 1412. Third wall 1404 may be positioned above and adjacentto first wall 1408 as shown in FIG. 14. In embodiments, third wall 1404,in addition to other functionalities, is used to provide a layer ofprotection for first wall 1408. Having third wall 1404 prevents damageto first wall 1408 that may occur when handling container 1400, and alsoavoids any direct contact of hands or other objects with first wall1408.

In embodiments, third wall 1404 and second wall 1412 may be made fromsimilar material, which in embodiments is similar to the materialsdescribed above with respect to wall 1208. Third wall 1404 and secondwall 1412 may be made of any suitable material including polymers. Insome embodiments, third wall 1404 and second wall 1412 may be made froma transparent or translucent material, non-limiting examples includingpolycarbonate, acrylics, polystyrene, polysulfone, polyethylene,polyolefin, polypropylene, polyvinylchloride, or combinations thereof.The use of a transparent or translucent material may be useful inembodiments where the material within container 1400 may be subjected toa pathogen reduction process that involves the use of a photosensitizerand illumination. In these embodiments, container 1400 may be able to beused as an illumination container. In embodiments, wall 1404 is alsobiocompatible, including at temperatures and pressures typical of alyophilization process. In embodiments, third wall 1404 and wall 1412include a polyolefin material. In embodiments, walls 1404 and 1408 maybe made of different materials.

First wall 1408 may in some embodiments be made from a material that ispermeable to at least some gasses. For example, 1408 may be made of amaterial that has a relatively high permeability to water vapor but lowpenetration of liquid water, i.e., is water resistant. Furthermore, inother embodiments, first wall 1408 is also made of a material that isbiocompatible. Examples of possible materials for use in first wall 1408include materials made from flashspun high-density polyethylene (HDPE)and polytetrafluoroethylene (PTFE). In one embodiment, first wall 1408may include a non-woven textile that includes fibers made from flashspunHDPE. In other embodiments, the wall 1408 may be made from copolymerssuch as polyethylene copolymers, vinyl copolymers, acrylic copolymers,polypropylene copolymers, or amide copolymers that may be cast on asubstrate (e.g., woven or nonwoven textile). In one embodiment, firstwall 1408 may be made of an acrylic copolymer cast on a nylon nonwoventextile.

In embodiments, first wall 1408 has a water vapor transmission ofgreater than about 15 perms, greater than about 20 perms, greater thanabout 25 perms, greater than 30 perms, and even greater than about 35perms. In some embodiments, first wall 1408 has a water vaporpermeability of between about 10 perms to about 700 perms, such asbetween about 20 perms and about 650 perms, or between about 30 permsand about 600 perms. Also, in some embodiments, the first wall 1408 mayhave a water resistance (i.e. hydrostatic head) of greater than about100 cm, greater than 150 cm, greater than about 200 cm, and even greaterthan about 250 cm. In some embodiments, first wall 1408 has a waterresistance value of between about 50 cm to about 400 cm, such as betweenabout 100 cm and about 350 cm, or between about 150 cm and about 300 cm.It is noted that in some embodiments, first wall 1408 may have any ofthe above-mentioned water vapor transmission values in combination withany of the above-mentioned water resistance values.

As shown in FIG. 14, first wall 1408 is attached to both walls 1404 and1412 at one or more joints 1424. Therefore, in addition to otherproperties, the walls are also made of materials that are compatiblewith each other to allow them to be attached together to form container1400. The walls 1404, 1408, and 1412 may be attached together using oneor more suitable techniques, some non-limiting examples including heatsealing, ultrasonic welding, RF welding, solvent welding, laser welding,and adhesive bonding.

In one embodiment, container 1400 is used to lyophilize a biologicalfluid such as plasma 1444. In this embodiment, wall 1408 may be made ofa material with a water vapor transmission of greater than about 75perms and a water resistance of greater than about 100 cm so that duringa sublimation step (e.g., sublimation of ice), water vapor may escapethrough wall 1408 and into volume 1448. Wall 1404 may include one ormore openings that allow gasses, e.g., water vapor, to escape into theenvironment from volume 1448. The water resistance of wall 1408 willprevent any water vapor that may condense in volume 1448 from leakinginto volume 1440 and rehydrating the lyophilized plasma.

FIG. 15 illustrates a cross sectional view of a three walled container1500 with a volume 1540 maintaining a biological fluid, for example,plasma 1544. As shown in FIG. 15, container 1500 includes a third wall1528, a first wall 1504, and a second wall 1508. As shown in FIG. 15,third wall 1528 may be positioned above and adjacent to first wall 1504.

In embodiments, second wall 1508 may be made from material similar tothe materials described above with respect to wall 1208 (FIGS. 12 and13). Second wall 1508 may be made of any suitable material includingpolymers. In some embodiments, second wall 1508 may be made from atransparent or translucent material, non-limiting examples includingpolycarbonate, acrylics, polystyrene, polysulfone, polyethylene,polyolefin, polypropylene, polyvinylchloride, or combinations thereof.The use of a transparent or translucent material may be useful inembodiments where the material within container 1500 may be subjected toa pathogen reduction process that involves the use of a photosensitizerand illumination. In these embodiments, container 1500 may be able to beused as an illumination container. In embodiments, second wall 1508 mayalso be biocompatible, including at temperatures and pressures typicalof a lyophilization process. In embodiments, third wall 1528 includes apolyolefin material.

Third wall 1528 and first wall 1504 may in some embodiments be made froma material that is permeable to at least some gasses. For example, thirdwall 1528 and first wall 1504 may be made of a material that has arelatively high permeability to water vapor but low penetration ofliquid water, i.e., is water resistant. Furthermore, in otherembodiments, third wall 1528 and first wall 1504 may also be made of amaterial that is biocompatible. Examples of possible materials for usein third wall 1528 and first wall 1504 include materials made fromflashspun high-density polyethylene (HDPE) and polytetrafluoroethylene(PTFE). In one embodiment, third wall 1528 and first wall 1504 mayinclude a non-woven textile that includes fibers made from flashspunHDPE. In another embodiment, third wall 1528 may include a cast polymer,cast on a non-woven textile.

In embodiments, third wall 1528 and first wall 1504 may have a watervapor transmission of greater than about 45 perms, greater than about 60perms, greater than about 75 perms, greater than 90 perms, and evengreater than about 105 perms. In some embodiments, third wall 1528 andfirst wall 1504 may have a water vapor permeability of between about 50perms to about 900 perms, such as between about 100 perms and about 850perms, or between about 150 perms and about 800 perms. Also, in someembodiments, the third wall 1528 and first wall 1504 may have a waterresistance (i.e. hydrostatic head) of greater than about 75 cm, greaterthan 125 cm, greater than about 175 cm, and even greater than about 225cm. In some embodiments, third wall 1528 and first wall 1504 may have awater resistance value of between about 25 cm to about 500 cm, such asbetween about 50 cm and about 400 cm, or between about 100 cm and about300 cm. It is noted that in some embodiments, third wall 1528 and firstwall 1504 may have any of the above-mentioned water vapor transmissionvalues in combination with any of the above-mentioned water resistancevalues.

As shown in FIG. 15, first wall 1504 (and in some embodiments third wall1528) may be attached to wall 1508 at one or more joints 1524.Therefore, in addition to other properties, first wall 1504 and secondwall 1508 may also be made of materials that are compatible with eachother to allow them to be attached together to form container 1500. Thewalls 1528, 1504, and 1508 may be attached together, in variouscombinations, using one or more suitable techniques, some non-limitingexamples including heat sealing, ultrasonic welding, RF welding, solventwelding, laser welding, adhesive bonding, and/or combinations thereof.

It is noted that in some embodiments, third wall 1528 and first wall1504 may be made from the same or similar material and/or materials withsimilar properties, non-limiting examples including thickness, tearstrength, toughness, water vapor transmission, water resistance, etc.However, in other embodiments, third wall 1528 and first wall 1504 maydiffer in properties. For example, in some embodiments, third wall 1528may be thicker than first wall 1504 in order to provide additionalrobustness to container 1500. In other embodiments, third wall 1528 mayhave a higher water vapor transmission, so that water vapor transportedthrough first wall 1504 is more easily transported through third wall1528 and into the environment. As yet another example, third wall 1528may have a higher water resistance as well as be a more effectivebarrier against microorganisms in order to prevent water from seepinginto volume 1540 and maintain the sterility of volume 1540.

Although not shown, in embodiments, container 1500 may include a fourthwall above third wall 1528. The fourth wall may be added as anadditional layer of protection. Similar to third layer 1404 of container1400, the fourth layer may prevent damage to third wall 1528 that mayoccur when handling container 1500, and also avoids any direct contactof hands or other objects with third wall 1528.

FIGS. 16-17C illustrate embodiments of a container 1600 that may be usedto store material for lyophilization and after lyophilization. FIG. 16illustrates a front view of container 1600. FIGS. 17A-17C illustratevarious cross-sectional views of container 1600 taken at line AA (shownin FIG. 16). In some embodiments, container 1600 may be used tolyophilize a biological fluid such as whole blood or a blood component.However, embodiments of the present invention are not limited thereto.Any material, liquid or solid, may be lyophilized and stored usingembodiments of container 1600.

As illustrated in FIG. 16, container 1600 includes a first chamber 1604and a second chamber 1608. As described below, in the embodiment shownin FIGS. 16-17C, chamber 1604 may be used during lyophilization of amaterial, with chamber 1608 used to store the lyophilized material untilit is rehydrated and used. Other embodiments may provide for differentstructures, designs, or components, which may include a first chamberfor storing material during lyophilization and a second chamber forstoring material after lyophilization.

First chamber 1604 includes a port 1612 through which material, such asblood or a blood component (e.g., human plasma), may enter chamber 1604.Chamber 1608 includes a port 1616 through which a hydration fluid mayenter chamber 1608. Chamber 1608 also includes a port 1620 through whicha rehydrated material may exit chamber 1608, e.g., a rehydrated bloodcomponent such as plasma may exit through port 1620 and be infused intoa patient.

Referring to FIGS. 17A-17C, chamber 1604 includes a first wall 1624 anda second wall 1628, which is attached to the first wall, forming aninterior volume 1632 of chamber 1604. As noted above, chamber 1604 maybe used to store material during lyophilization; the material forlyophilization may be stored in volume 1632.

First wall 1624 in embodiments may be made from flexible polymericmaterials. In some embodiments, wall 1624 may be made from transparentor translucent polymeric materials, non-limiting examples includingpolycarbonate, acrylics, polystyrene, polysulfone, polyethylene,polyolefin, polypropylene, polyvinylchloride, or combinations thereof.

As shown in FIG. 16, second wall 1628 may in embodiments include aregion 1656 that has a permeability to a gas that is greater than thepermeability of the first wall 1624. Because chamber 1604 is used tostore material during lyophilization, the region 1656 is provided toallow a gas, e.g., water vapor, to escape volume 1632 duringlyophilization.

Region 1656 may in embodiments be made from materials that haverelatively high permeability to a gas, such as water vapor but are stillrobust enough to hold the material without leaking. In some embodiments,region 1656 may be made from one or more of the following materials:flashspun high-density polyethylene (HDPE), polytetrafluoroethylene(PTFE), acrylics cast on woven or nonwoven textiles, amides cast onwoven or nonwoven textiles, and/or combinations thereof.

In some embodiments, region 1656 may be larger than shown in FIG. 16,such as making up more than half of wall 1628. In other embodiments, theentire wall 1628 may be made from a material that is permeable to gas,such as water vapor. In these embodiments, there would be no region1656; instead, the entire wall 1628 would provide the region allowinggas, e.g., water vapor, to escape volume 1632. In yet other embodiments,there may be several regions 1656 of the same or different sizes as partof wall 1628.

The remaining portions of wall 1628 (and in embodiments also wall 1624),may be made from any suitable material. In embodiments, wall 1628 and/orwall 1624 may be made from flexible polymeric materials. Examples offlexible polymeric materials that may be used in portions of wall 1628and in wall 1624 include without limitation: polycarbonate, acrylics,polystyrene, polysulfone, polyethylene, polyolefin, polypropylene,polyvinylchloride, or combinations thereof.

As noted above, container 1600 also has chamber 1608, which include afirst wall 1636 that is attached to a second wall 1640 to define aninterior volume 1644. In embodiments, chamber 1608 is designed to storematerial (e.g., whole blood or a blood component) after lyophilization.Walls 1636 and 1640 may therefore in embodiments be made from flexiblepolymeric materials that are robust and can withstand long storageperiods and significant handling. In some embodiments, walls 1636 and1640 may be made from transparent or translucent polymeric materials,non-limiting examples including polycarbonate, acrylics, polystyrene,polysulfone, polyethylene, polyolefin, polypropylene, polyvinylchloride,or combinations thereof.

In addition to chambers 1604 and 1608, container 1600 also has a pathway1648, shown in FIGS. 17A, 17B, and 17C as 1648A, 1648B, and 1648Crespectively. Pathway 1648 allows volumes 1632 and 1644 to be incommunication, e.g., fluid communication, but may also be sealed with aseal 1652 to prevent communication between volumes 1632 and 1644.

FIG. 17A illustrates pathway 1648A sealed by seal 1652. In thisembodiment, there is no communication, e.g., fluid communication,between volumes 1632 and 1644. This embodiment may be used when materialin chamber 1604 is being lyophilized. Seal 1652 would prevent material,e.g., liquid or solid, from entering volume 1644. Maintaining thematerial in volume 1632 may make the lyophilization process moreefficient because wall 1628 (which defines volume 1632) includes region1656 through which gas, e.g., water vapor, escapes.

Seal 1652 may be created using any suitable material, mechanism, orprocess. Some non-limiting examples of seals that may be used as seal1652 include welds, adhesives, frangibles, clamps, bonds, and/orcombinations thereof. Creation of seal 1652 may involve mechanicalclamping, welding (e.g., radio frequency, ultrasonic, induction, laser,etc.), heat sealing, adhesives, or other means. In embodiments, the seal1652 may be opened to allow communication between volumes 1632 and 1644.

FIG. 17B illustrates pathway 1648B as open to allow communicationbetween volume 1632 and 1644. Similarly, FIG. 17C illustrates pathway1648C as open to allow communication between volume 1632 and 1644. FIGS.17B and 17C illustrate two different embodiments where the pathway 1648is opened different amounts, but both allowing material to flow fromvolume 1632 to volume 1644. It is noted that depending on the seal type,pathway 1648 may be opened to different extents.

The embodiments shown in FIGS. 17B and 17C may be used after alyophilization process has been completed. Lyophilized material involume 1632 may be transferred though pathway 1648B or 1648C into volume1644. After the material is transferred, pathway 1648B or 1648C may besealed again to prevent material from flowing back into volume 1632. Insome embodiments, chamber 1604 may be removed after the lyophilizedmaterial is transferred into volume 1644 and pathway 1648B or 1648C issealed. As one example, seal 1652 may be created by welding wall 1636 to1640 and at the same time cutting walls 1624 and 1628 to separatechamber 1604 from chamber 1608.

Below is a description of a process according to embodiments of thepresent invention that provide for lyophilizing and storing whole bloodor blood components, such as plasma. However, the present invention isnot limited thereto and may be used to lyophilize and store othermaterials. Also, the description below may refer to specific features ofcontainer 1600 shown in FIGS. 16-17C, however the present invention isnot limited to being performed by any particular structure and mayutilize different features in other embodiments.

In embodiments, a liquid plasma product may be placed into a container,such as container 1600. More specifically, the plasma product may beplaced into the chamber 1604 through port 1612. Chamber 1604 may providea sterile barrier as well as allow the lyophilization of the plasma withwater vapor escaping through a wall, such as through region 1656.

After a volume of liquid plasma is placed in chamber 1604, container1600 may be placed in an apparatus for lyophilizing materials, such asapparatus 100 (FIG. 1) or apparatus 200 (FIG. 2). The liquid plasma mayundergo a lyophilization process.

It is noted that during the lyophilization of the plasma, a seal, suchas seal 1652 may be in the pathway 1648, which prevents communicationbetween the volumes of chambers 1604 and 1608. That is, there may be nofluid communication between the volumes 1632 and 1644.

After the lyophilization of the plasma, container 1600 may be removedfrom the lyophilization apparatus. Seal 1652 may be removed/opened toallow communication through pathway 1648. The lyophilized plasma maythen be transferred from volume 1632 into volume 1644. Seal 1652 maythen be closed or resealed. In some embodiments, chamber 1604 may beremoved from chamber 1608 after, or as part of resealing pathway 1648.

Chamber 1608 may be designed in some embodiments to be robust and madefrom materials that withstand the rigors of being significantly handled,e.g., carried in a backpack in a military environment or handling inmobile use such as an ambulance (helicopter or vehicle). Accordingly,the lyophilized plasma may be stored in chamber 1608 for relativelylarge periods of time until it is used, e.g., rehydrated and infusedinto a patient.

In some embodiments, before the lyophilized plasma is used, arehydration liquid may be transferred into chamber 1608 through port1616. After some time to hydrate the plasma (e.g., less than fiveminutes), the rehydrated plasma may be infused into a patient throughport 1620.

In the embodiments where plasma is lyophilized, stored and transfusedusing container 1600, the two chambers 1604 and 1608, as well as otherportions of the container, may be maintained sterile and remain a“closed” system throughout the process of filling, lyophilizing,transferring between chambers, storing, and using.

FIGS. 18A and 18B illustrate a front view of another container 1800consistent with embodiments of the present invention. In the embodimentshown in FIGS. 18A and 18B, container 1800 initially has a singlechamber 1804 with an interior volume 1808. Container 1800 includes afirst portion 1804A (e.g., top portion) and a second portion 1804B(e.g., bottom portion).

Container 1800 includes a first wall (not shown) and a second wall 1828,which is attached to the first wall, forming an interior volume 1808 ofchamber 1804. The first wall in embodiments may be made from flexiblepolymeric materials. In some embodiments, the first wall may be madefrom transparent or translucent polymeric materials, non-limitingexamples including polycarbonate, acrylics, polystyrene, polysulfone,polyethylene, polyolefin, polypropylene, polyvinylchloride, orcombinations thereof.

As illustrated in FIG. 18A, the top portion of wall 1828 includes a gaspermeable region 1856 that allows a gas, such as water vapor, to escapevolume 1808. The bottom portion of wall 1828 does not include a gaspermeable region.

Region 1856 has a permeability to a gas that is greater than thepermeability of the first wall and the remaining portion of second wall1828. Region 1856 may be provided to allow a gas, e.g., water vapor, toescape volume 1808 during lyophilization.

Region 1856 may in embodiments be made from materials that haverelatively high permeability to a gas, such as water vapor but are stillrobust enough to hold material to be lyophilized without leaking. Insome embodiments, region 1856 may be made from one or more of thefollowing materials: flashspun high-density polyethylene (HDPE),polytetrafluoroethylene (PTFE), acrylics cast on woven or nonwoventextiles, amides cast on woven or nonwoven textiles, and/or combinationsthereof. The remaining portions of wall 1828 may be made from anysuitable material. In embodiments, portions of second wall 1828 may bemade from a flexible polymeric material. Examples of flexible polymericmaterials that may be used in portions of wall 1828 include withoutlimitation: polycarbonate, acrylics, polystyrene, polysulfone,polyethylene, polyolefin, polypropylene, polyvinylchloride, orcombinations thereof.

In embodiments of using container 1800, material to be lyophilized maybe transferred into volume 1808 through one or more of ports 1816 and/or1820. After the material has been lyophilized, the lyophilized materialmay be moved, manually or automatically (e.g., by a mechanical system),within chamber 1804 so that most of the lyophilized material is in thebottom portion 1804B. After the lyophilized material has been moved tobottom portion 1804B, the bottom portion 1804B may be separated from topportion 1804A, as shown in FIG. 18B.

As part of the separation, or before the separation of portions 1804Aand 1804B, a seal 1860 may be created on a top edge of bottom portion1804B. The seal 1860 may ensure that the lyophilized material ismaintained in a sterilized environment through-out the process ofseparating the bottom portion 1804B from the top portion 1804A. Inembodiments, seal 1860 may be created using any suitable sealing device.Non-limiting examples of devices that may be used in embodiments tocreate seal 1860 as well as separate bottom portion 1804B from topportion 1804A, include without limitation: ultrasonic welders, laserwelders, radio frequency welders, high frequency welders, inductionwelders, hot bar welders, impulse welders, hot gas welders, infraredwelders, and/or microwave welders.

Bottom portion 1804B may be designed in some embodiments to be robustand made to withstand the rigors of being significantly handled, e.g.,carried in a backpack in a military environment or handling in mobileuse such as an ambulance (helicopter or vehicle). Accordingly, thelyophilized material may be stored in bottom portion 1804B until it isused.

In some embodiments, before the lyophilized material in bottom portion1804B is used, a rehydration liquid may be transferred into bottomportion 1804B through one or more ports 1816 and/or 1820. After sometime to hydrate the material, the material may be used and transferredout of bottom portion 1804B through one or more ports 1816 and/or 1820.

FIGS. 19A-19C illustrates a side view of another embodiment of acontainer 1900 that may be used to store material for lyophilization andafter lyophilization. Container 1900 includes a first chamber 1904 and asecond chamber 1908. As described below, chamber 1904 may be used inembodiments during lyophilization of a material with chamber 1908 beingused to store the lyophilized material after lyophilization.

First chamber 1904 includes a port 1912 through which material, e.g.plasma, whole blood, or other blood component, may be introduced intochamber 1904. In addition, chamber 1904 include a first wall 1916attached to a second wall 1920 through a side wall 1924 to form aninterior volume of chamber 1904. It is noted that in some embodiments,side wall 1924, or a portion thereof, may be part of first wall 1916 orsecond wall 1920. For example, in embodiments first wall 1916 and/orsecond wall 1920 may be formed from a sheet with dimensions that allowthe sheet to be folded to create side wall 1924 or a portion of sidewall 1924. In other embodiments, wall 1920 may be in the form of a traythat includes side walls 1924. In embodiments, side wall 1924 extendsbetween first wall 1916 and second wall 1920 along a perimeter of firstwall 1916 and second wall 1920.

As shown in FIGS. 19A and 19B, side wall 1924 includes creases 1928A,1928B, and 1928C, which allow side wall 1924 to collapse and expand.FIG. 19A illustrates side wall 1924 collapsed, which provides lessvolume within the interior volume of chamber 1904. FIG. 19B illustratesside wall 1924 in an expanded state, which provides greater volumewithin the interior volume of chamber 1904.

As shown in FIGS. 19B, chamber 1904 is connected to chamber 1908 througha pathway 1932. In FIG. 19A, clip 1936 is positioned to close and/orseal pathway 1932 to avoid communication between chamber 1904 and 1908.

Referring back to chamber 1904, wall 1920 and/or side wall 1924 may, inembodiments, be made from flexible polymeric materials. In someembodiments, wall 1920 and/or side wall 1924 may be made fromtransparent or translucent polymeric materials, non-limiting examplesincluding polycarbonate, acrylics, polystyrene, polysulfone,polyethylene, polyolefin, polypropylene, polyvinylchloride, orcombinations thereof.

Wall 1916 may include materials that are permeable to a gas. That is,wall 1916 may include material that has a greater permeability to a gas(e.g., water vapor) than the permeability of wall 1920. Because chamber1904 is used to store material during lyophilization, the permeablematerial is provided to allow a gas, e.g., water vapor, to escapechamber 1904 during lyophilization. In embodiments, the entire wall 1916may be made of a gas permeable material. In other embodiments, only aregion of wall 1916 may be include the permeable material, similar towall 1828 of container 1800 (FIG. 18A).

The permeable materials that may be used in wall 1916 may in embodimentsbe made from materials that have relatively high permeability to a gas,such as water vapor but are still robust enough to hold the materialwithout leaking. In some embodiments, wall 1916 may be made from one ormore of the following materials: flashspun high-density polyethylene(HDPE), polytetrafluoroethylene (PTFE), acrylics cast on woven ornonwoven textiles, amides cast on woven or nonwoven textiles, and/orcombinations thereof.

In embodiments, wall 1916 may have a water vapor transmission of greaterthan about 65 perms, greater than about 85 perms, greater than about 105perms, greater than 125 perms, and even greater than about 145 perms. Insome embodiments, wall 1916 may have a water vapor permeability ofbetween about 70 perms to about 825 perms, such as between about 95perms and about 775 perms, or between about 120 perms and about 725perms. Also, in some embodiments, the wall 1916 may have a waterresistance (i.e. hydrostatic head) of greater than about 70 cm, greaterthan about 85 cm, greater than about 100 cm, and even greater than about115 cm. In some embodiments, wall 1916 may have a water resistance valueof between about 20 cm to about 525 cm, such as between about 25 cm andabout 500 cm, or between about 30 cm and about 475 cm. It is noted thatin some embodiments, wall 1916 may have any of the above-mentioned watervapor transmission values in combination with any of the above-mentionedwater resistance values.

In those embodiments where wall 1916 includes only a portion ofpermeable material, the remaining portions may be made from any suitablematerial. Examples of flexible polymeric materials that may be used inportions of wall 1916 include without limitation: polycarbonate,acrylics, polystyrene, polysulfone, polyethylene, polyolefin,polypropylene, polyvinylchloride, or combinations thereof.

As noted above, container 1900 also has chamber 1908, which includes afirst wall 1940 that is attached to a second wall 1944 to define aninterior volume of chamber 1908 (see FIGS. 19B & 19C). In embodiments,chamber 1908 is designed to store material (e.g., whole blood or a bloodcomponent) after lyophilization. Walls 1940 and 1944 may therefore inembodiments be made from flexible polymeric materials that are robustand can withstand long storage periods and significant handling. In someembodiments, walls 1940 and 1944 may be made from transparent ortranslucent polymeric materials, non-limiting examples includingpolycarbonate, acrylics, polystyrene, polysulfone, polyethylene,polyolefin, polypropylene, polyvinylchloride, or combinations thereof.

Chamber 1908 also includes a port 1948. In embodiments, port 1948 may beused to remove material from chamber 1908. In one embodiment,lyophilized material within chamber 1908 may be rehydrated in chamber1908 and then removed from chamber 1908 through port 1948. As oneexample, lyophilized plasma may be stored within chamber 1908. Afteradding a rehydrating liquid to the lyophilized plasma, the rehydratedplasma may be infused into a patient through port 1948. In otherembodiments, chamber 1908 may include more than one port. In theseembodiments, port 1948 may be used to introduce reconstitution fluid torehydrate the lyophilized plasma, with the other port being used toinfuse the reconstituted plasma to a patient.

In FIG. 19A, chamber 1908 is rolled up so that it does not take up asmuch space as when it is extended as shown in FIG. 19B. The ability ofchamber 1908 to be rolled up (FIG. 19A) allows container 1900 to take upless shelf space in a lyophilization apparatus (e.g., 100 or 200), forexample. If chamber 1908 could not be rolled up, then container 1900would take up shelf space that could be used to lyophilize additionalmaterial.

In addition to chambers 1904 and 1908, container 1900 also has a pathway1932. Pathway 1932 allows volumes 1904 and 1908 to be in communication,e.g., fluid communication, but may also be sealed with a seal to preventcommunication between volumes 1904 and 1908.

FIG. 19A illustrates pathway 1932 sealed by clip 1936. In thisembodiment, there is no communication, e.g., fluid communication,between volumes 1904 and 1908. This embodiment may be used when materialin chamber 1904 is being lyophilized. Clip 1936 prevents material thatmay be in chamber 1904, e.g., liquid or solid, from entering the volumeof chamber 1908. Maintaining the material in volume 1904 may make thelyophilization process more efficient because wall 1916 includes a gaspermeable material which allows gas, e.g., water vapor, to escape. Ifmaterial were allowed to migrate into chamber 1908, any gas would haveto travel to chamber 1904 to escape through wall 1916, which may prolongthe lyophilization process.

In other embodiments, instead of clip 1936, the seal between chamber1904 and 1908 may be created using any suitable material, mechanism, orprocess. Some non-limiting examples of seals that may be used instead ofclip 1936 include welds, adhesives, frangibles, bonds, and/orcombinations thereof. Creation of a seal between chambers 1904 and 1908may involve mechanical clamping, welding (e.g., radio frequency,ultrasonic, induction, laser, etc.), heat sealing, adhesives, and/orother means.

FIG. 19B illustrates clip 1936 removed, and pathway 1932 open to allowcommunication between volume 1904 and 1908. The clip 1936 may be removedand pathway 1932 opened after material has been lyophilized in chamber1904. With pathway 1932 open, the lyophilized material may then betransferred from chamber 1904 to chamber 1908 for longer term storage.

After the lyophilized material has been transferred into chamber 1908,chamber 1904 and chamber 1908 may be sealed again to preventcommunication between the two chambers. As shown in FIG. 19C chamber1904 may be separated from chamber 1908 with chamber 1908 being sealedwith seal 1952. Chamber 1908 may then be used to store the lyophilizedmaterial for a relatively long period of time, e.g., about two years.

In embodiments of using container 1900, material to be lyophilized maybe transferred into volume 1904 through port 1912 in one embodiment itmay be plasma. As a result of introducing the plasma into chamber 1904,side wall 1924 may utilize creases 1928A-C to expand the volume ofchamber 1904 (see chamber 1904 in FIG. 19B). While chamber 1908 is stillin a rolled up state (see chamber 1908 in FIG. 19A), container 1900 maybe place in a lyophilization apparatus such as apparatus 100 (FIG. 1) orapparatus (FIG. 2) and have the plasma lyophilized. As noted above, thelyophilization process may involve steps such as exposing the materialand container 1900 to a first pressure below atmospheric pressure,freezing, and sublimating a component of the material. Gasses generatedduring the sublimation process may escape chamber 1904 through the gaspermeable material of wall 1916.

After the material has been lyophilized, the lyophilized material may bemoved, manually or automatically (e.g., by a mechanical system), fromchamber 1904 to chamber 1908. Initially, clip 1936 is removed, whichallows communication between chamber 1904 and 1908. The lyophilizedmaterial may then be moved to chamber 1908. Chamber 1908 may be sealedand chamber 1904 may then be separated from chamber 1908, as shown inFIG. 19C.

As part of the separation, or before the separation of chamber 1904 and1908, a seal 1952 may be created on an end of chamber 1908. The seal1952 may ensure that the lyophilized material is maintained in asterilized environment through-out the process of separating the chamber1904 and chamber 1908. In embodiments, seal 1952 may be created usingany suitable sealing device. Non-limiting examples of devices that maybe used in embodiments to create seal 1952 as well as separate chamber1904 and chamber 1908, including without limitation: ultrasonic welders,laser welders, radio frequency welders, high frequency welders,induction welders, hot bar welders, impulse welders, hot gas welders,infrared welders, and/or microwave welders.

FIGS. 20A-20C illustrates a side view of another embodiment of acontainer 2000 that may be used to store material for lyophilization andafter lyophilization. Container 2000 includes a first chamber 2004 and asecond chamber 2008. As described below, chamber 2004 may be used inembodiments during lyophilization of a material with chamber 2008 beingused to store the lyophilized material for storage until it isrehydrated and used.

First chamber 2004 includes a port 2012 through which material, e.g.plasma, whole blood, or other blood component, may be introduced intochamber 2004. In addition, chamber 2004 includes a first wall 2016attached to a second wall 2020 to form an interior volume of chamber2004. It is noted that in some embodiments, wall 2020 may provide somedepth for material that is stored in container chamber 2004. In theseembodiments, wall 2020 may be in the form of a tray.

As shown in FIG. 20B, chamber 2004 is connected to chamber 2008 througha pathway 2032. In FIG. 20A, clip 2036 is positioned to close and/orseal pathway 2032 to avoid communication between chamber 2004 and 2008.

Referring back to chamber 2004, wall 2020, in embodiments, may be madefrom flexible polymeric materials. In some embodiments, wall 2020 may bemade from transparent or translucent polymeric materials, non-limitingexamples including polycarbonate, acrylics, polystyrene, polysulfone,polyethylene, polyolefin, polypropylene, polyvinylchloride, orcombinations thereof.

Wall 2016 may include materials that are permeable to a gas. Wall 2016may include material that has a greater permeability to a gas (e.g.,water vapor) than the permeability of wall 2020. Because chamber 2004 isused to store material during lyophilization, the permeable material isprovided to allow a gas, e.g., water vapor, to escape chamber 2004during lyophilization. In embodiments, the entire wall 2016 may be madeof a gas permeable material. In other embodiments, only a region of wall2016 may be made of the permeable material, similar to wall 1828 ofcontainer 1800 (FIG. 18A).

The permeable materials that may be used in wall 2016 may in embodimentsbe made from materials that have relatively high permeability to a gas,such as water vapor but are still robust enough to hold the materialwithout leaking. In some embodiments, wall 2016 may be made from one ormore of the following materials: flashspun high-density polyethylene(HDPE), polytetrafluoroethylene (PTFE), acrylics cast on woven ornonwoven textiles, amides cast on woven or nonwoven textiles, and/orcombinations thereof.

In embodiments, wall 2016 may have a water vapor transmission of greaterthan about 135 perms, greater than about 150 perms, greater than about165 perms, greater than 180 perms, and even greater than about 195perms. In some embodiments, wall 2016 may have a water vaporpermeability of between about 115 perms to about 725 perms, such asbetween about 130 perms and about 700 perms, or between about 145 permsand about 675 perms. Also, in some embodiments, the wall 2016 may have awater resistance (i.e. hydrostatic head) of greater than about 80 cm,greater than about 90 cm, greater than about 100 cm, and even greaterthan about 110 cm. In some embodiments, wall 2016 may have a waterresistance value of between about 20 cm to about 500 cm, such as betweenabout 30 cm and about 450 cm, or between about 40 cm and about 400 cm.It is noted that in some embodiments, wall 2016 may have any of theabove-mentioned water vapor transmission values in combination with anyof the above-mentioned water resistance values.

In those embodiments where wall 2016 includes only a portion ofpermeable material, the remaining portions may be made from any suitablematerial. Examples of flexible polymeric materials that may be used inportions of wall 2016 include without limitation: polycarbonate,acrylics, polystyrene, polysulfone, polyethylene, polyolefin,polypropylene, polyvinylchloride, or combinations thereof.

As noted above, container 2000 also has chamber 2008, which include afirst wall 2040 that is attached to a second wall 2044 to define aninterior volume of chamber 2008 (see FIG. 20B). In embodiments, chamber2008 is designed to store material (e.g., whole blood or a bloodcomponent) after lyophilization. Walls 2040 and 2044 may therefore inembodiments be made from flexible polymeric materials that are robustand can withstand long storage periods and significant handling. In someembodiments, walls 2040 and 2044 may be made from transparent ortranslucent polymeric materials, non-limiting examples includingpolycarbonate, acrylics, polystyrene, polysulfone, polyethylene,polyolefin, polypropylene, polyvinylchloride, or combinations thereof.

Chamber 2008 also includes a port 2048. In embodiments, port 2048 may beused to remove material from chamber 2008. In one embodiment,lyophilized material within chamber 2008 may be rehydrated in chamber2008 and then removed from chamber 2008 through port 2048. As oneexample, lyophilized plasma may be stored within chamber 2008. Afteradding a rehydrating liquid to the lyophilized plasma, the rehydratedplasma may be infused into a patient through port 2048. In otherembodiments, chamber 2008 may include more than one port. In theseembodiments, port 2048 may be used to introduce reconstitution fluid torehydrate the lyophilized plasma, with the other port being used toinfuse the reconstituted plasma to a patient.

In FIG. 20A, chamber 2008 is rolled up so that it does not take up asmuch space as when it is extended as shown in FIG. 20B. The ability ofchamber 2008 to be rolled up (FIG. 20A) allows container 2000 to take upless shelf space in a lyophilization apparatus (e.g., FIG. 1 or FIG. 2),for example. If chamber 2008 could not be rolled up, then container 2000would take up shelf space that could be used to lyophilize additionalmaterial.

In addition to chambers 2004 and 2008, container 2000 also has a pathway2032. Pathway 2032 allows volumes 2004 and 2008 to be in communication,e.g., fluid communication, but may also be sealed with a seal to preventcommunication between volumes 2004 and 2008.

FIG. 20A illustrates pathway 2032 sealed by clip 2036. In thisembodiment, there is no communication, e.g., fluid communication,between volumes 2004 and 2008. This embodiment may be used when materialin chamber 2004 is being lyophilized. Clip 2036 prevents material thatmay be in chamber 2004, e.g., liquid or solid, from entering the volumeof chamber 2008. Maintaining the material in volume 2004 may make thelyophilization process more efficient because wall 2016 includes a gaspermeable material which allows gas, e.g., water vapor, to escape.

In other embodiments, instead of clip 2036, the seal between chamber2004 and 2008 may be created using any suitable material, mechanism, orprocess. Some non-limiting examples of seals that may be used instead ofclip 2036 include welds, adhesives, frangibles, bonds, and/orcombinations thereof. Creation of a seal between chambers 2004 and 2008may involve mechanical clamping, welding (e.g., radio frequency,ultrasonic, induction, laser, etc.), heat sealing, adhesives, or othermeans.

FIG. 20B illustrates clip 2036 removed, and pathway 2032 open to allowcommunication between volume 2004 and 2008. The clip 2036 may be removedand pathway 2032 opened after material has been lyophilized in chamber2004. With pathway 2032 open, the lyophilized material may then betransferred from chamber 2004 to chamber 2008 for longer term storage.

After the lyophilized material has been transferred into chamber 2008,chamber 2004 and chamber 2008 may be sealed again to preventcommunication between the two chambers. As shown in FIG. 20C chamber2004 may be separated from chamber 2008 with chamber 2008 being sealedwith seal 2052. Chamber 2008 may then be used to store the lyophilizedmaterial for a relatively long period of time, e.g., about two years.

Referring now to FIG. 21, an embodiment of a system 2100 for fillingcontainers with a biological fluid is illustrated. In one embodiment,system 2100 is used to pool blood or blood components for laterlyophilizing. In one embodiment, system 2100 is used to pool humanplasma. The description below expands on the embodiment for poolingplasma; however it is noted that other embodiments may involve poolingother biological fluids.

System 2100 includes ports 2104 where a number of containers, e.g.,bags, with plasma may be connected. The plasma may in embodiments comefrom different donors, with each bag containing plasma from a singledonor. In some embodiments, the plasma may be selected based on theblood types of the donors. For example, the plasma may all be fromdonors of a single blood type or of compatible blood types. In oneembodiment, the specific blood types of the donors may be selected tocreate a universal blood type. The use of plasma from donors with bloodtypes, A, B, and AB may in embodiments be used to create universalplasma that may be infused into patients of any blood type.

After being connected to ports 2104, plasma may be passed through filter2108, which may be used to remove some components or contaminants fromthe plasma. In one embodiment, filter 2108 is designed to remove cells,such as leukocytes, from the plasma. Although system 2100 illustratesonly a single filter 2108, in other embodiments, system 2100 may includea series of filters each for filtering the same, or a different,component or contaminant from the plasma.

After filtering, the plasma is pooled together in container 2112, whichin embodiments is a bag that can accommodate a relatively large volumeof plasma, e.g., at least the volume of plasma in the containersconnected to ports 2104. While in container 2112, the plasma may undergoagitation to mix the plasma. In these embodiments, system 2100 mayinclude additional features that effect the agitation, non-limitingexamples including, rollers, motors, ultrasonic transducers, powersource(s), etc.

System 2100 may in embodiment rely on gravity to create the flow ofplasma from, and to, different parts of system 2100. In otherembodiments, pumps can be utilized to pump plasma from, and to,different parts of system 2100. In the specific embodiment shown in FIG.21, pump 2116 is used to move plasma from container 2112 into containers2120. It is noted that in other embodiments, pumps may be used in otherparts of the system, for example, a pump may be used to move plasma fromfilter 2108 to container 2112.

Although containers 2120 may be any suitable container for holdingplasma, embodiments, the containers are similar to container 1200 (FIGS.12-13), 1600 (FIGS. 17-18), 1800 (FIG. 18), 1900 (FIG. 19), and/or 2000(FIG. 20). As described in greater detail below, system 2100 may be usedwith containers 2120 in a process for pooling biological fluids (e.g.,plasma), lyophilizing the fluids into a solid, storing the solid,reconstituting the solid into the biological fluid, and using thebiological fluid in a patient.

FIG. 22 illustrates a second embodiment of a system 2200 that may beused to pool and fill containers with a biological fluid. System 2200includes similar features to system 2100 but also includes someadditional features. Similar to system 2100, system 2200 includes ports2204 where a number of containers, e.g., bags, with plasma may beconnected. The plasma may in embodiments come from different donors,with each bag containing plasma from a single donor. As noted above, theplasma may be selected based on the blood types of the donors to createplasma for a single blood type or create universal plasma that may beinfused into patients of any blood type.

Plasma flows from ports 2204 through filter 2208, which is similar tofilter 2108 and may be used to remove some components or contaminantsfrom the plasma, e.g., cells such as leukocytes. In other embodiments,system 2200 may include a series of filters each for filtering the same,or a different, component or contaminant from the plasma.

After filtering, the plasma is pooled together in container 2212, whichin embodiments is a bag. System 2200 may include additional componentsthat effect agitation of the plasma, not limiting examples including,rollers, motors, ultrasonic transducers, power source(s), etc.

System 2200 also includes pump 2216, in embodiments, which is used tomove plasma from container 2212 into filter 2220. It is noted that inother embodiments, pumps may be used in other parts of the system, forexample, a pump may be used to move plasma from filter 2208 to container2212.

Filter 2220 may be used to concentrate the plasma by removing water andsome salt from the plasma. In one embodiment, filter 2220 may be ahollow fiber membrane filter, which removes water, salt, and some lowermolecular weight molecules from the plasma. The water, salt, andmolecules from filter 2220 are collected in container 2228, where theymay be stored for later use, or discarded. Although system 2200illustrates only a single filter 2220, in other embodiments, system 2200may include a series of filters each removing at least some water orother component from the plasma.

Pump 2232 is used to move plasma from filter 2220 into containers 2236.Although containers 2236 may be any suitable container for holdingconcentrated plasma, in embodiments, the containers may be similar tocontainers 1200 (FIGS. 12-13) 1600 (FIGS. 16-17C), 1800 (FIG. 18), 1900(FIG. 19), and/or 2000 (FIG. 20). System 2200 may be used with thecontainers in processes for pooling biological fluids (e.g., plasma),lyophilizing the fluids into a solid, storing the solid, reconstitutingthe solid into the biological fluid, and using the biological fluid in apatient.

FIG. 23 illustrates an embodiment of a system 2300 for fillingcontainers with a biological fluid. System 2300 is similar to system2100 described above, however it includes additional pathogen reductionfeatures. In embodiments, system 2300 is used to pool blood or bloodcomponents and pathogen reduce the blood or blood components prior tolyophilizing. In one embodiment, system 2200 is used to pool andpathogen reduce human plasma. The description below expands on theembodiment for pooling and pathogen reducing plasma; however it is notedthat other embodiments may involve pooling other biological fluids.

System 2300 includes ports 2304 where a number of containers, e.g.,bags, with plasma may be connected. The plasma may in embodiments comefrom different donors, with each bag containing plasma from a singledonor. In some embodiments, the plasma may be selected based on theblood types of the donors. For example, the plasma may all be fromdonors of a single blood type or of compatible blood types. In oneembodiment, the specific blood types of the donors may be selected tocreate a universal blood type. The use of plasma from donors with bloodtypes, A, B, and AB may in embodiments be used to create universalplasma that may be infused into patients of any blood type.

After being connected to ports 2304, plasma may be passed through filter2308, which may be used to remove some components or contaminants fromthe plasma. After filtering, the plasma may be pooled together incontainer 2312, which in embodiments is a bag that can accommodate arelatively large volume of plasma, e.g., at least the volume of plasmain the containers connected to ports 2304. While in container 2312, theplasma may undergo agitation to mix the plasma. In these embodiments,system 2300 may include additional features that effect the agitation,non-limiting examples including, rollers, motors, ultrasonictransducers, power source(s), etc.

System 2300 may in embodiment rely on gravity to create the flow ofplasma from, and to, different parts of system 2300. In otherembodiments, pumps can be utilized to pump plasma from, and to,different parts of system 2300. For example, pump 2316, may be used topump plasma from container 2324 to containers 2320.

System 2300 also includes a container 2324 that stores a photosensitizerthat may be used in pathogen reducing the plasma pooled in container2312. In embodiments, container 2324 may store an endogenousphotosensitizer non-limiting examples including flavins such asriboflavin.

Container 2312 may be made from materials that are transparent or atleast translucent to the wavelength of light used in the pathogenreduction process. In some embodiments, container 2312 may be made offlexible polymeric materials that are transparent or at leasttranslucent to light of wavelengths between about 250 nm to about 600nm.

After the plasma is pooled together in container 2312, thephotosensitizer may be mixed into the plasma in container 2312. System2300 may include additional components that effect agitation of theplasma and photosensitizer, not limiting examples including, rollers,motors, ultrasonic transducers, power source(s), etc.

After the photosensitizer has been mixed into the plasma in container2312, the plasma may be exposed to a light source such as light source2328. In embodiments, light source 2328 may be of a wavelength thatinteracts with the photosensitizer to pathogen reduce the plasma.Examples and further description of pathogen reduction, which may beused in embodiments, including combinations of light wavelengths andphotosensitizers, are provided in U.S. Pat. No. 6,548,241; U.S. Pat. No.6,258,577; and U.S. Pat. No. 6,277,337, which are all herebyincorporated by reference in their entirety as if set forth herein infull.

After exposure to the light source 2328, the pathogen reduced plasma maybe directed to the containers 2320 (by pump 2316) for laterlyophilization. Any suitable container for holding the pathogen reducedplasma may be used as container 2320. In embodiments, the containers maybe similar to container 1200 (FIGS. 12-13), 1600 (FIGS. 16C-17), 1800(FIG. 18), 1900 (FIG. 19), and/or 2000 (FIG. 20).

FIG. 24 illustrates an embodiment of a system 2400 for fillingcontainers with a biological fluid. System 2400 is similar to system2200 described above, however it includes additional pathogen reductionfeatures. In embodiments, system 2400 is used to pool blood or bloodcomponents and pathogen reduce the blood or blood components prior tolyophilizing. In one embodiment, system 2400 is used to pool andpathogen reduce human plasma.

Plasma flows from ports 2404 through filter 2408, which is similar tofilter 2208 and may be used to remove some components or contaminantsfrom the plasma, e.g., cells such as leukocytes. In other embodiments,system 2400 may include a series of filters each for filtering the same,or a different, component or contaminant from the plasma.

After filtering, the plasma is pooled together in container 2412, whichin embodiments is a bag. System 2400 may include additional componentsthat effect agitation of the plasma, not limiting examples including,rollers, motors, ultrasonic transducers, power source(s), etc.

System 2400 also includes pump 2416, which is used to move plasma fromcontainer 2412 into filter 2420. It is noted that in other embodiments,pumps may be used in other parts of the system, for example, a pump maybe used to move plasma from filter 2408 to container 2412.

Filter 2420 may be used to concentrate the plasma by removing water andsome salt from the plasma. In one embodiment, filter 2420 may be ahollow fiber membrane filter, which removes water, salt, and some lowermolecular weight molecules from the plasma. The water, salt, andmolecules from filter 2420 may be collected in container 2428, wherethey may be stored for later use, or discarded. Although system 2400illustrates only a single filter 2420, in other embodiments, system 2400may include a series of filters each removing at least some water orother component from the plasma.

Pump 2432 is used to move plasma from filter 2420 into container 2440.After the plasma is moved into container 2440, a photosensitizer storedin container 2244 may be mixed into the plasma in container 2440. System2400 may include additional components that effect agitation of theplasma and photosensitizer, not limiting examples including, rollers,motors, ultrasonic transducers, power source(s), etc.

Container 2440 may be made from materials that are transparent or atleast translucent to the wavelength of light used in the pathogenreduction process. In some embodiments, container 2440 may be made offlexible polymeric materials that are transparent or at leasttranslucent to light of wavelengths between about 275 nm to about 625nm.

After the photosensitizer has been mixed into the plasma in container2440, the plasma may be exposed to a light source such as light source2448. In embodiments, light source 2448 may be of a wavelength thatinteracts with the photosensitizer to pathogen reduce the plasma.Examples and further description of pathogen reduction, which may beused in embodiments, including combinations of light wavelengths andphotosensitizers, are provided in U.S. Pat. No. 6,548,241; U.S. Pat. No.6,258,577; and U.S. Pat. No. 6,277,337, which are all herebyincorporated by reference in their entirety as if set forth herein infull.

After exposure to the light source 2448, the pathogen reduced plasma maybe pumped by pump 2432 to the containers 2436 for later lyophilization.Any suitable container for holding the pathogen reduced plasma may beused as containers 2436. In embodiments, the containers may be similarto container 1200 (FIGS. 12-13), 1600 (FIGS. 16-17C), 1800 (FIG. 18),1900 (FIG. 19), and/or 2000 (FIG. 20).

In systems 2300 and 2400, the light sources (2328 and 2448) may includeadditional components and features in addition to a light source. Forexample, in FIG. 25, a system 2500 is shown that may be used as lightsources 2328 (FIG. 23) and/or 2448 (FIG. 24). As shown in FIG. 25,system 2500 includes a light source 2504, as well as an agitator 2508(e.g., shaker table) for agitating the fluid in container 2518 (inembodiments containers 2312 or 2440) while exposing the fluid to lightsource 2504.

FIG. 26 illustrates another example embodiment of an apparatus 2600,e.g., a pathogen reduction apparatus that may be used as part of lightsources (2328 and 2448). As illustrated in FIG. 26, apparatus 2600includes a light source 2608 on a door 2616 that opens and closes. Whendoor 2616 is opened, a container with fluid may be placed on a table2612, which in embodiments has a window where a second light source 2604is positioned to expose the fluid in the container to the light source2604. Door 2616 can be closed and the fluid in the container can beexposed to both light sources 2604 and 2608. In embodiments, table 2612may shake to agitate the fluid in the container before, after, or duringexposure to light sources 2604 and 2608

In some embodiments, systems (or portions of the systems) 2100, 2200,2300, and 2400 may be implemented as disposable sets that interface withsome permanent components of the systems, e.g., light sources. Forexample, in some embodiments, ports, filters, containers, may bemanufactured as a disposable set, with tubing connecting the variouscomponents of the system. Permanent components, such as pumps and/orlight sources may interface with the disposable components.

FIG. 27 illustrates a process 2700 for lyophilizing, storing,reconstituting, storing, and transfusing a biological fluid, which inFIG. 27 may be plasma. The process 2700 may be performed using asuitable container, such as a bag with features described above withrespect to containers 1200 (FIGS. 12 and 13), 1600 (FIG. 16-17C), 1800(FIG. 18), 1900 (FIGS. 19), and 2000 (FIG. 20). The description below isdirected to the processing of plasma using a container referenced belowas bag 1200; however, other embodiments are not limited thereto.

At 2704, bag 1200 is filled with plasma. In embodiments, the bag 1200may be filled using a system for pooling plasma, such as systems 2100,2200, 2300, and/or 2400. At 2708, the plasma in bag 1200 is lyophilizedin bag 1200 using an apparatus which may include one or more features ofplate structures 800 (FIG. 8), 900 (FIG. 9), and/or 1000 (FIG. 10). Thelyophilization process may involve steps as described below with respectto flow diagram 2800, including without limitation, evaporating liquidfrom the plasma while subjecting the plasma to a first pressure (e.g.,below atmospheric pressure), pressing the remaining plasma whilefreezing to create a frozen plasma, and sublimating a portion of thefrozen plasma while subjecting the plasma to a second pressure.

It is noted that although FIG. 27 illustrates the use of a containersuch as container 1200, in other embodiments a different container maybe used. As one example, containers such as 1600 (FIGS. 16 and 17C),1800 (FIG. 18), 1900 (FIG. 19), and/or 2000 (FIG. 20) may be used. Inthese embodiments, one chamber (or portion) of the container may be usedfor the lyophilization of the plasma. After the lyophilization, thelyophilized plasma may be moved to a second chamber, or portion, of thecontainer and the first chamber (or portion) then separated from thefirst portion.

At 2712, bag 1200, with the lyophilized plasma, is packaged for storage.The packaging may involve a number of different steps and utilizedifferent packaging materials. In process 2700, a sleeve 2740 is placedover bag 1200 to provide additional robustness and is generally kept onbag 1200 during subsequent process steps. The sleeve 2740 may be madefrom any suitable material such as a polymer. In embodiments, sleeve2740 may be made from a transparent or translucent polymer that isflexible, such as polycarbonate, acrylic, polystyrene, polysulfone,polyethylene, polyolefin, polypropylene, polyvinylchloride, orcombinations thereof.

The bag 1200 and sleeve 2740 may also be placed in a foil bag 2744. Thefoil bag 2744 provides additional protection that may prolong theviability of the lyophilized plasma in bag 1200. The foil bag 2744 withits metalized layer may block light, be water proof, may include a watervapor desiccant, and be vacuum packed, in order to extend the shelf lifeof the lyophilized plasma. The use of a flexible bag 1200, flexiblesleeve 2740, and flexible foil bag 2744 provides a flexible product thatcan be easily stored and transported, such as in a back pack. Inembodiments, the lyophilization of the plasma along with the packagingmay allow the plasma to have a shelf life of at least two years.

A bag 2748, which includes reconstitution fluid, may be packaged in foilbag 2744 with the bag 1200. When needed, the lyophilized plasma in bag1200 may be reconstituted using the fluid in bag 2748, see step 2716 inFIG. 27. Bag 2748 may be connected to bag 1200 to allow thereconstitution fluid to flow into bag 1200. After a short time (e.g.,two minutes or less), and in some embodiments some agitation, thereconstituted plasma is ready to be infused into a patient at 2720.

In other embodiments, at 2724, the reconstituted plasma may be movedinto bag 2748 for additional storage at step 2728. In these embodiments,bag 2748 may include features, such as materials that allow liquids tobe stored for some period of time. In some embodiments, thelyophilization of the plasma and the use of bag 2748 allow thereconstituted plasma to be stored for at least a day before beinginfused into a patient at 2720 from bag 2748.

Referring now to FIG. 28, a flow chart 2800 is illustrated for a processof lyophilizing material according to an embodiment. Although specificdevices may be described below for performing steps in flow chart 2800,embodiments are not limited thereto. For example, some steps may bedescribed as performed by a processor, while others are performed by oneor more features of a lyophilization apparatus. This is done merely forillustrative purposes, and flow chart 2800 is not limited to beingperformed by any specific device, feature, or component. In embodiments,flow chart 2800 may be implemented by a lyophilization apparatus, suchas apparatus 100 or 200, with features of one or more plate structures800, 900, or 1000 described above with respect to FIGS. 8, 9, and 10.

Furthermore, any material may be lyophilized using the processillustrated in flow chart 2800 including biological liquids such asblood and blood components. In one specific embodiment, plasma islyophilized using the process illustrated in FIG. 28; however this ismerely one example. The description of flow chart 2800 is made withrespect to a biological liquid, e.g., plasma, but this is done merelyfor purposes of illustration and is not intended to limit theapplication of flow chart 2800 to lyophilize other materials.

Flow 2800 starts at 2804. Flow 2800 may in embodiments include optionalpathogen reduction step or steps 2806. One embodiment of a pathogenreduction process is described below with respect to FIG. 29 and flow2900.

After the optional pathogen reduction process (step 2806), a liquid (orother material to be lyophilized) is maintained within a container atstep 2808. In embodiments, the container is designed to be used to storethe liquid prior to lyophilization, in the lyophilization, to store thelyophilized material for a relatively long period of time, toreconstitute the lyophilized material, and in some embodiments to infusethe reconstituted material into a patient. In one embodiment, thecontainer may include one or more features described above with respectto container 1200. In other embodiments, containers 1600, 1800, 1900, or2000 may be used where one chamber (or portion) of the container is usedfor lyophilization and another chamber (or portion) is used to store thelyophilized material. In embodiments, step 2808 may include sub-stepssuch as placing the container on a shelf within a lyophilizationapparatus such as apparatus 100 or 200.

Returning to flow 2800, from 2808 flow passes to 2812 where thecontainer and liquid is subjected to a first pressure. In embodiments,the pressure is created by a lyophilization apparatus. The firstpressure may be below atmospheric pressure and may depend on thespecific material (e.g., liquid) being lyophilized. In embodiments wherethe plasma includes water, the first pressure may be less than about 100Torr absolute pressure, less than about 75 Torr, less than about 50Torr, and even less than about 25 Torr. In other embodiments, the firstpressure may be greater than about 5×10⁻² Torr, greater than about1×10⁻¹ Torr, greater than about 5×10⁻¹ Torr, greater than about 1 Torr,greater than about 1 Torr, greater than about 5 Torr, or even greaterthan about 10 Torr. In yet other embodiments, the first pressure mayrange from about 40 Torr to about 0 Torr, from about 30 Torr to about 1Torr, from about 20 to about 2 Torr, or even from about 15 Torr to about3 Torr. These are merely some examples of ranges of the first pressureand other embodiments may utilize different pressures.

From step 2812, flow passes to optional step 2816 where liquid from thematerial being lyophilized may be evaporated. In some embodiments, suchas when the material is plasma, the liquid being evaporated may bewater. Because the material is below atmospheric pressure, only arelatively small amount of energy may be required to evaporate liquidfrom the material. The energy may be supplied for example by a thermalfluid circulating through a plate of the shelf or by an IR radiator thatis part of the shelf in a lyophilization apparatus.

Step 2816 may be performed in some embodiments to reduce the volume ofthe liquid to be lyophilized. Without being bound by theory, it isbelieved that by performing step 2816 to reduce the volume of theliquid, a subsequent sublimation step may be performed more quicklyand/or efficiently.

Step 2820 follows step 2816. At step 2820, the liquid is cooled tofreeze liquid into a solid and create a frozen product. In embodiments,a thermal fluid circulating through a plate of the shelf may removeenergy and cool the liquid to freeze the liquid into a solid. In someembodiments, step 2820 may involve a number of optional sub-steps. Forexample, sub-step 2824 may involve evaporating a portion of the liquid.The evaporation may cool the liquid to an extent that it freezes into asolid. In some embodiments, sub-step 2824 may be performed as part ofstep 2816 described above.

Additionally, in some embodiments, sub-step 2828 may be performed toshape, e.g. by pressing the container and the liquid within thecontainer. Without being bound by theory, it is believed that pressing(or otherwise shaping) the container and the liquid (or other material)in the container, as part of the freezing step 2820, may create a moreuniform cross-section when the liquid (or other material) is cooled andfrozen. Accordingly, it is believed that the more uniform cross-sectionwill increase the efficiency of removing a component, such as ice, fromthe frozen product during a subsequent sublimation step. In other words,reducing variations in thickness may allow sublimation to occur at asimilar rate throughout the material improving the efficiency of theprocess.

In some embodiments, the pressure may be applied using a shelf system300 or 500 such as described above with respect to FIGS. 3-6. In otherembodiments, the pressure for pressing the material may be providedusing a different system, such as a flexible balloon or bladder that maybe filled with a fluid. The balloon or bladder may be positioned abovethe material to be lyophilized. The balloon or bladder may be filledwith a fluid (e.g., gas or liquid) which cause the balloon or bladder toexpand and press the liquid during freezing. This is merely onealternative, and any way for applying some pressure on the container,and the liquid, may be utilized with other embodiments to shape thecontainer and/or material (e.g., liquid).

At step 2832, the container and the frozen product is subjected to asecond pressure. In embodiments, the pressure is created by thelyophilization apparatus. The second pressure may be below atmosphericpressure and below the first pressure. The specific pressure may dependon the specific material being lyophilized. In embodiments where thematerial may include water, the second pressure may be less than about5×10⁻¹ Torr, less than about 1×10⁻¹ Torr, less than about 5×10⁻² Torr,or even less than less than about 1×10⁻² Torr. In other embodiments, thesecond pressure may be greater than about 1×10⁻⁴ Torr, greater thanabout 5×10⁻⁴ Torr, greater than about 1×10⁻³ Torr, greater than about5×10⁻³ Torr, or even greater than about 1×10⁻² Torr. These are merelysome examples of ranges of the second pressure and other embodiments mayutilize different pressures.

After step 2832, a portion of the frozen product, e.g., the solidcreated at step 2820 from remaining liquid, may be sublimated at step2836. Energy may be required to sublimate material from the frozenproduct. The energy may be supplied for example by a thermal fluidcirculating through a plate of the shelf. In some embodiments, step 2832may involve a sub-step 2840 of adding infrared energy using an IRradiator that may be part of the shelf in the lyophilization apparatus.In embodiments where the shelf includes a plate structure similar tostructures 800 or 900, the IR energy may be added from the top, whilethermal energy from a thermal fluid may be added from the bottom. Flowthen ends at 2844.

Although flow 2800 has been described with steps listed in a particularorder, the present disclosure is not limited thereto. In otherembodiments, steps may be performed in different order, in parallel, orany different number of times, e.g., before and after another step.Also, as indicated above, flow 2800 includes some optionalsteps/sub-steps. However, those steps above that are not indicated asoptional should not be considered as essential to the invention, but maybe performed in some embodiments of the present invention and not inothers.

In some embodiments, portions of flow 2800 may be performed as part of acustomized lyophilization process run on a lyophilization apparatus orsystem. For example, an operator may utilize an application running on acomputer system (e.g. computer system described 3300 below) to createcustom processes that may include one or more steps of flow 2800. Theprocesses may then be run in a lyophilization apparatus or system tolyophilize material. In some embodiments, once created, the customprocesses may be run by simply pressing a button.

FIG. 29 illustrates a flow chart 2900 for a process of lyophilizingmaterial according to another embodiment. Although specific devices maybe described below for performing steps in flow chart 2900, embodimentsare not limited thereto. For example, some steps may be described asperformed by a pathogen reduction apparatus, while others are performedby one or more features of a lyophilization apparatus. This is donemerely for illustrative purposes, and flow chart 2900 is not limited tobeing performed by any specific device, feature, or component. Inembodiments, flow chart 2900 may be implemented by a lyophilizationapparatus, such as apparatus 100 or 200.

Furthermore, any material may be lyophilized using the processillustrated in flow chart 2900 including biological liquids such asblood and blood components. In one specific embodiment, plasma islyophilized using the process illustrated in FIG. 29; however this ismerely one example. The description of flow chart 2900 is made withrespect to a biological liquid, e.g., plasma, but this is done merelyfor purposes of illustration and is not intended to limit theapplication of flow chart 2900 to lyophilize other materials.

Flow 2900 starts at 2904 and passes to step 2908 where liquid is pooledin a container. In embodiments, systems such as systems 2400 and 2500may be used to pool a number of units of e.g., plasma, into a largercontainer. Also, in embodiments step 2908 may involve agitating theliquid being pooled in the container to effect mixing of the pooledliquid. The agitation may involve the use of mechanisms to agitate theliquid, some non-limiting examples including, pumps, shakers, aerators,rollers, motors, ultrasonic transducers, power source(s), etc.

After step 2908, flow passes to step 2912 where a pathogen reductioncomposition is added. In embodiments, the pathogen reduction compositionmay include an endogenous photosensitizer, such as a flavin, includingriboflavin. In other embodiments, the pathogen reduction composition mayadditionally include other compositions. For example, the pathogenreduction composition may include surfactants, buffers, salts, pHmodifiers, solvents, etc.

At step 2916, the liquid with the pathogen reduction composition isexposed to light. Step 2916 may involve the use of any suitable systemthat provides a light source that exposes the liquid, with the pathogenreduction composition, to the necessary wavelength of light to reducepathogens in the liquid. In embodiments, a system such as system 2500may be used to both agitate and expose the liquid to a light source. Inother embodiments, a pathogen reduction apparatus such as apparatus 2600illustrated in FIG. 26 may be used to both agitate the liquid, as wellas expose the liquid to a light source. The agitation may involve theuse of mechanisms to agitate the liquid, some non-limiting examplesincluding, pumps, shakers, aerators, rollers, motors, ultrasonictransducers, power source(s), etc.

After step 2916, the liquid may be lyophilized using any suitablelyophilization process 2920. For example, in some embodiments, flow 2900may pass to flow 2800 described above where the liquid, which has beenpathogen reduced, is lyophilized. In other embodiments, thelyophilization process may involve flow 3200 discussed below withrespect to FIG. 32. Flow 2900 then ends at 2936.

FIGS. 30 and 31 illustrate embodiments of systems for lyophilizingmaterial by using primarily IR (infrared) energy. As discussed abovewith respect to plate structures 800, 900, 1000, and flow 2800 (FIG.28), the present invention provides for lyophilization processes thatmay involve the use of IR energy in addition, or in lieu of, thermalenergy. Systems 3000 (FIGS. 30) and 3100 (FIG. 31) are examples ofsystems that may be used in embodiments that utilize primarily IR energyin the sublimation step of a lyophilization process. Accordingly, thedescription below assumes that the material has been frozen using otherfeatures of system 3000 or system 3100, or the material may have beenfrozen in a different system or apparatus (e.g., systems 100 and 200using plate structures 800, 900 and/or 1000).

FIG. 30 illustrates a system 3000 for sublimating a material incontainer 3004 as part of a lyophilization process. In some embodiments,container 3004 may include two walls attached to define an interiorvolume where material to be lyophilized may be placed. The materialsthat may be used for the walls of container 3004 may be made frommaterials that have relatively high permeability to a gas, such as watervapor, but are still robust enough to hold the material without leaking.In some embodiments, the walls of container 3004 may be made from one ormore of the following materials: flashspun high-density polyethylene(HDPE), polytetrafluoroethylene (PTFE), acrylics cast on woven ornonwoven textiles, amides cast on woven or nonwoven textiles, and/orcombinations thereof.

Container 3004, with frozen material inside, is place on a shelf 3008that is designed to allow gas that is transported through container 3004to dissipate. In embodiments, shelf 3008 may simply include someperforations that allow gas to flow away from container 3004. In otherembodiments, shelf 3008 may be made from a screen or other porousstructure that allows gas to dissipate away from container 3004.

In addition, system 3000 includes IR radiators 3012 and 3016. As shownin FIG. 30, the IR radiators 3012 and 3016 are positioned so that theyradiate IR energy to both sides of container 3004. As previously noted,sublimation may occur at a surface of a material. Using the design shownin FIG. 30, two surfaces may be subjected to sublimation at the sametime, which may reduce the overall lyophilization time of the material.

FIG. 31 illustrates another embodiment of a system 3100 for sublimatingmaterial in containers (3108, 3112, 3116, and 3120) as part of alyophilization process. Similar to container 3004, containers 3108,3112, 3116, and 3120 may include two walls attached to define aninterior volume where material to be lyophilized may be placed in theinterior volume. The materials that may be used for the walls of thecontainers 3108, 3112, 3116, and 3120 may be made from materials thathave relatively high permeability to a gas, such as water vapor, but arestill robust enough to hold the material without leaking. In someembodiments, the walls of containers 3108, 3112, 3116, and 3120 may bemade from one or more of the following materials: flashspun high-densitypolyethylene (HDPE), polytetrafluoroethylene (PTFE), acrylics cast onwoven or nonwoven textiles, amides cast on woven or nonwoven textiles,and/or combinations thereof.

System 3100 includes a hanger 3104 from which the containers 3108, 3112,3116, and 3120 with frozen material inside, may be hung. Hanger 3104 maybe designed with various hooks or other features for holding containers3108, 3112, 3116, and 3120 vertically.

System 3100 includes IR radiators 3124, 3128, 3132, 3136, and 3140. Asshown in FIG. 31, the IR radiators 3124, 3128, 3132, 3136, and 3140 arepositioned so that they radiate IR energy to both sides of containers3108, 3112, 3116, and 3120. As previously noted, sublimation may occurat a surface of a material. Using the design shown in FIG. 31, twosurfaces may be subjected to sublimation at the same time, which mayreduce the overall lyophilization time of the material.

FIG. 32 illustrates a flow chart 3200 for a process of lyophilizingmaterial according to an embodiment. Although specific devices may bedescribed below for performing steps in flow chart 3200, embodiments arenot limited thereto.

Flow 3200 starts at 3204 and passes to step 3208 where material ismaintained in a container. The material may be in some embodiments aliquid, such as blood or blood components. In one specific embodiment,the material is human plasma. The container where the material is storedmay in embodiments include walls with materials that have relativelyhigh permeability to a gas, such as water vapor, but are still robustenough to hold the material during processing. Non-limiting examples ofmaterials that may be used include: flashspun high-density polyethylene(HDPE), polytetrafluoroethylene (PTFE), acrylics cast on woven ornonwoven textiles, amides cast on woven or nonwoven textiles, and/orcombinations thereof.

Step 3208 may in embodiments involve moving material from one containerto another. For example, in the embodiment of human plasma, step 3208may involve pooling a number of units of plasma and transferring volumesof plasma into containers and maintaining the plasma in the containers.

After step 3208, flow 3200 passes to step 3212 where the material isfrozen. In some embodiments step 3212 may involve the use of shelveswith plate structures that may include features of plate structures 800(FIGS. 8A-8B), 900 (FIG. 9), or 1000 (FIG. 10). For example, step 3208may involve placing the container on a shelf that includes pathways forcirculating a thermal fluid that cools the material and freezes anyliquid in the material at step 3212.

Step 3212 may involve a number of other sub-steps. For example, in oneembodiment, step 3212 involves sub-step 3216 where the container andmaterial are shaped, e.g., pressed during freezing. The shaping may beperformed using one or more shelf systems such as systems 300 (FIG. 3)or 500 (FIG. 5), which may use plate structures 800 (FIGS. 8A-8B), 900(FIG. 9), and/or 1000 (FIG. 10). In other embodiments, step 3212 mayinvolve other steps or structures (e.g., forms, textures, stamps, etc.)for shaping the material during the freezing.

Flow 3200 passes from step 3212 to step 3220 where the material issubjected to a pressure that is below atmospheric pressure. The pressuremay depend on the specific material being lyophilized. In embodimentswhere the material may include water, the pressure may be less thanabout 5×10−1 Torr, less than about 1×10−1 Torr, less than about 5×10−2Torr, or even less than less than about 1×10−2 Torr. In otherembodiments, the second pressure may be greater than about 1×10−4 Torr,greater than about 5×10−4 Torr, greater than about 1×10−3 Torr, greaterthan about 5×10−3 Torr, or even greater than about 1×10−2 Torr. Theseare merely some examples of ranges of the second pressure and otherembodiments may utilize different pressure ranges. Step 3220 may beperformed in some embodiments using lyophilization apparatuses such asapparatuses 100 (FIG. 1) and/or 200 (FIG. 2).

From 3220, flow passes to step 3224, where IR energy is added to thematerial. Step 3224 may involve in embodiments adding IR energy to onlyone side of the container. In other embodiments, step 3224 may involveadding IR energy to two or more sides of a container. Step 3224 may beperformed in systems that provide IR energy some non-limiting examplesincluding systems 3000 (FIG. 30) and/or 3100 (FIG. 31). Other examplesof structures that may be used to add IR energy include plate structures800 (FIGS. 8A-8B), 900 (FIG. 9), or 1000 (FIG. 10).

As part of step 3224, IR energy may be provided to effect changes in thematerial. For example, IR energy may be provided to sublimate acomponent 3228 of the material, e.g., ice. Additional IR energy may beprovided to not only sublimate a component, but also to remove acomponent that may be absorbed or adsorbed in the material (step 3232),e.g., water of hydration. Flow 3200 ends at 3236.

FIG. 33 illustrates example components of a basic computer system 3300upon which embodiments of the present invention may be implemented. Forexample, systems 100 (FIG. 1) or 200 (FIG. 2) may incorporate featuresof the basic computer system 3300 shown in FIG. 33. Computer system 3300includes output device(s) 3304, and input device(s) 3308. Outputdevice(s) 3304 may include, among other things, one or more displays,including CRT, LCD, and/or plasma displays. Output device(s) 3304 mayalso include printers, speakers etc. Input device(s) 3308 may include,without limitation, a keyboard, touch input devices, a mouse, voiceinput device, scanners, etc.

Basic computer system 3300 may also include one or more processor(s)3312 and memory 3316, according to embodiments of the present invention.In embodiments, the processor(s) 3312 may be a general purposeprocessor(s) operable to execute processor executable instructionsstored in memory 3316. Processor(s) 3312 may include a single processoror multiple processors, according to embodiments. Further, inembodiments, each processor may be a single core or a multi-coreprocessor, having one or more cores to read and execute separateinstructions. The processors may include, in embodiments, generalpurpose processors, application specific integrated circuits (ASICs),field programmable gate arrays (FPGAs), and other integrated circuits.

The memory 3316 may include any tangible storage medium for short-termor long-term storage of data and/or processor executable instructions.The memory 3316 may include, for example, Random Access Memory (RAM),Read-Only Memory (ROM), or Electrically Erasable Programmable Read-OnlyMemory (EEPROM). Other storage media may include, for example, CD-ROM,tape, digital versatile disks (DVD) or other optical storage, tape,magnetic disk storage, magnetic tape, other magnetic storage devices,etc.

Storage 3328 may be any long-term data storage device or component.Storage 3328 may include one or more of the devices described above withrespect to memory 3316. Storage 3328 may be permanent or removable.

Computer system 3300 also includes communication devices 3336. Devices3336 allow system 3300 to communicate over networks, e.g., wide areanetworks, local area networks, storage area networks, etc., and mayinclude a number of devices such as modems, hubs, network interfacecards, wireless network interface cards, routers, switches, bridges,gateways, wireless access points, etc.

The components of computer system 3300 are shown in FIG. 33 as connectedby system bus 3340. It is noted, however, that in other embodiments, thecomponents of system 3300 may be connected using more than a single bus.

It will be apparent to those skilled in the art that variousmodifications and variations can be made to the methods and structure ofthe present invention without departing from its scope. Thus it shouldbe understood that the invention is not to be limited to the specificexamples given. Rather, the invention is intended to cover modificationsand variations within the scope of the following claims and theirequivalents.

While example embodiments and applications of the present invention havebeen illustrated and described, it is to be understood that theinvention is not limited to the precise configuration and resourcesdescribed above. Various modifications, changes, and variations apparentto those skilled in the art may be made in the arrangement, operation,and details of the methods and systems of the present inventiondisclosed herein without departing from the scope of the claimedinvention.

What is claimed is:
 1. A container for lyophilizing, storing, andtransfusing a blood component, the container comprising: a first wallmade from a porous material comprising a polymer cast on a nonwoventextile; and a second wall attached to the first wall to define aninterior volume of the container, wherein the second wall comprises aflexible polymeric material.
 2. The container of claim 1, wherein thefirst wall is permeable to at least one gas.
 3. The container of claim2, wherein the first wall is permeable to water vapor.
 4. The containerof claim 3, wherein the first wall is water resistant.
 5. The containerof claim 4, wherein the first wall has a water vapor transmission of atleast 15 perms.
 6. The container of claim 5, wherein the first wall hasa water resistance of greater than 100 cm.
 7. The container of claim 1,further comprising a port connector between the first wall and thesecond wall.
 8. The container of claim 1, further comprising lyophilizedhuman plasma in the interior volume.
 9. A container for lyophilizing andstoring a lyophilized blood component, the container comprising: a firstchamber comprising: a first wall made from a flexible polymeric materialand comprising a first permeability to water vapor; and a second wallattached to the first wall to define an interior volume of the firstchamber, wherein at least a portion of the second wall comprises aregion that has a second permeability to water vapor, the secondpermeability being higher than the first permeability; a second chamberfluidly connectable to the first chamber through a pathway, the secondchamber comprising: a third wall made from a flexible polymericmaterial; and a fourth wall attached to the third side wall to define aninterior volume of the second chamber; and a seal in the pathway, theseal isolating the first chamber from the second chamber, wherein theseal may be opened to allow communication from the first chamber to thesecond chamber through the pathway.
 10. The container of claim 9,wherein the seal comprises one or more of a clamp, a weld, a frangible,or combinations thereof.
 11. The container of claim 10, wherein thefirst chamber further comprises a first port for adding a bloodcomponent into the interior volume of the first chamber.
 12. Thecontainer of claim 11, wherein the second chamber further comprises asecond port for adding a rehydration fluid into the interior volume ofthe second chamber.
 13. The container of claim 12, wherein the secondchamber further comprises a third port for removing a rehydrated bloodcomponent from the interior volume of the first chamber.
 14. Thecontainer of claim 13, wherein the at least a portion of the second wallcomprises a nonwoven textile.
 15. A method of lyophilizing material, themethod comprising: maintaining a material in a container; subjecting thematerial to a first pressure; evaporating at least a portion of a liquidcomponent of the material; cooling the material to freeze any remainingliquid component into a solid; subjecting the material to a secondpressure which is less than the first pressure; and sublimating aportion of the solid.
 16. The method of claim 15, wherein theevaporating comprises adding thermal energy to the material.
 17. Themethod of claim 16, wherein the sublimating comprises adding thermalenergy to the material.
 18. The method of claim 17, wherein thesublimating comprises adding IR energy to the material.
 19. The methodof claim 18, further comprising, pressing the material during thecooling.
 20. A method of lyophilizing material, the method comprising:pooling liquid in a container to create pooled liquid; adding aphotosensitizer to the pooled liquid; exposing the pooled liquid withthe photosensitizer to a light source to create a pathogen reducedliquid; lyophilizing the pathogen reduced liquid, wherein thelyophilizing comprises: cooling the pathogen reduced liquid to freeze aliquid component to create a solid; subjecting the solid to a firstpressure, which is less than atmospheric pressure; and sublimating aportion of the solid.
 21. The method of claim 20, wherein thephotosensitizer comprises riboflavin.
 22. The method of claim 21,wherein the light source generates light with a wavelength in theultraviolet range.
 23. The method of claim 20, wherein the liquidcomprises human plasma.
 24. A system for use in lyophilizing a material,the system comprising: a first plate with a first surface; a secondplate with a second surface opposed to the first surface, the secondplate comprising channels for circulating a fluid; and a plate movingsystem operable to increase and decrease a space between the firstsurface and the second surface.
 25. The system of claim 24, furthercomprising an IR radiating material on the first plate, the IR radiatingmaterial comprising the first surface.
 26. The method of claim 24,wherein the first surface comprises features for imparting a macrotexture
 27. The method of claim 24, wherein the first plate and thesecond plate comprise the same structure.
 28. A method of preparing aliquid comprising a blood component for lyophilization, the methodcomprising: pooling a plurality of volumes of liquid comprising a bloodcomponent to generate a pooled volume of liquid; removing a portion ofliquid from the pooled volume of liquid to create a reduced volume ofliquid; and filling a plurality of containers with the reduced volume ofliquid, wherein the plurality of containers comprise a wall that ispermeable to water vapor.
 29. The method of claim 28, further comprisingreducing pathogens in the reduced volume of liquid.
 30. The method ofclaim 29, wherein the reducing pathogens comprises: adding aphotosensitizer to the reduced volume of liquid; and exposing thephotosensitizer and the reduced volume of liquid to a light source.